Annual Report - Alberta Innovates · 2019-08-21 · optimal health and healthcare. Within AIHS, we created the Partnership Office whose members have strong established relationships

Annual Report2014-15

ISSN 1918-3232 (Online) Annual Report (Alberta Innovates – Health Solutions)

Transforming health and wellbeing through research and innovation

2014-15 ANNUAL REPORT 1

T A B L E O F C O N T E N T S

Executive Summary ......................................................................................... 2-3

Accountability Statement ................................................................................... 4

Message from Board Chair ................................................................................. 5

Key Research and Innovation Initiatives ........................................................ 6-15

Management’s Discussion and Analysis ....................................................... 16-17

Operational Overview ...................................................................................... 18

Consolidated Financial Statements .............................................................. 19-38

Appendix A: AIHS Funding Awards ............................................................ 39-42

Appendix B: Currently Funded Projects & People ....................................... 43-63

2014-15 Annual Report

ALBERTA INNOVATES – HEALTH SOLUTIONS2

AIHS is able to perform a unique role in our province to address some of these issues through health research and innovation support. This role has three overlapping dimensions:

• Partner, broker and facilitator of targeted, high impact health initiatives;

• Catalyst for major capacity development in core areas critical to the support and competitiveness of our provincial health research and innovation environment;

• Funder of high quality, priority health research activity and enabler for moving the resulting innovations into use and development.

Mobilizing expertise and input from all stakeholders vested in contributing to better health and health services is the right way to tackle enormously complex problems that affect our people and our province. One of this past year’s highlights was the development of a strategic provincial partnership—the Health Research and Innovation Collaboratory (HRIC)—formed to accelerate research and innovation into health and healthcare. In addition to AIHS, this partnership includes:

• Alberta Health Services (AHS), our health delivery system;

• the ministries of Health and Innovation and Advanced Education;

• Alberta Innovates – Technology Futures (AITF);• the Alberta Academic Health Network (AHN),

representing our universities; and • community care providers, represented by the

Alberta Medical Association (AMA).

EXECUTIVE SUMMARY

Albertans face many issues when it comes to their health and their health care system. There are pockets of excellence in health care but there remain major variations in quality, access and outcomes. Our system is the most expensive in Canada. The parts of the system are not fully integrated, which is a particular challenge for the growing numbers of people with multiple chronic conditions, frailty, and mental health issues. Alberta Innovates – Health Solutions (AIHS) focuses on finding ways to accelerate the creation and uptake of research evidence to support health and health system effectiveness, quality and efficiency. The benefits to Albertans will be better ways of delivering care, improved patient experiences and outcomes, and cost savings.

32014-15 ANNUAL REPORT

This is the first time AIHS has formed such a partnership for system coordination on major projects with the potential for transformative changes in health delivery.

Initial HRIC processes, platforms and broad system priorities were developed over the past year to demonstrate proof of concept for this collaborative way of thinking and doing. The goal is to develop such a powerful value proposition that we attract partners from all sectors and areas of the world who want to work with us and invest in Alberta to deliver optimal health and healthcare.

Within AIHS, we created the Partnership Office whose members have strong established relationships with academia, industry and the health system. The Partnership Office serves as a receptor for the opportunities arising through HRIC or from other organizations and also takes a proactive approach—identifying new opportunities and delivering them with partners. The results of their work are new partners to the ecosystem who bring new funding to Alberta’s health researchers and innovators; new grants that focus on health system issues and the development of province-wide approaches to common issues such as data use.

We also saw the further development of Alberta’s SPOR SUPPORT Unit, a $48 million initiative jointly funded by AIHS and CIHR. The Unit—a virtual expertise and services hub for patient-oriented researchers in Alberta and the North West Territories—now has academic Leads appointed for each of the seven platforms who are preparing for the Unit opening its doors for business later in 2015.

The new focus on partnered activity heightens the need for reporting on the impact of our investments in research and innovation to our funding partners and to the people of Alberta. AIHS has a performance management and evaluation unit that has set the standard in the province for how to conduct impact assessments. In September, 2014 AIHS and international partners, AQuAS and Rand Europe, offered the first International School for Research Impact Assessment in Banff. Sixty participants from Alberta, the rest of Canada and from around the world participated in the intensive, hands-on school to learn how to conduct performance measurement and management. Building capacity to determine what works and what doesn’t in our broad health system is why performance management and evaluation is a defined platform for the HRIC.

The ongoing successes of our health research and innovation environment in Alberta are sustained through AIHS’s investment in a wide spectrum of activity in our research community with nearly $77.5 million dollars out the door in this last fiscal year. Over the past five years, the total of AIHS investments in health research and innovation is nearly $400M dollars, with most of that funding streamed to our provincial universities.

All of our activities aligned and will continue to align with the strategies and priorities identified by the Government of Alberta and our partners in Alberta’s research and innovation ecosystem. We are proud to uphold excellence and relevance in the area of health research and innovation for the province and for the ultimate benefit of Albertans.


The Alberta Innovates – Health Solutions annual report for the year ended March 31, 2015 was prepared under the Board’s direction in accordance with the Alberta Research and Innovation Regulation, the Fiscal Management Act, and ministerial guidelines established pursuant to the Fiscal Management Act. All material economic, environmental, or fiscal implications of which we are aware have been considered in the preparation of this report.

Robert A. Seidel, QCCHAIR, BOARD OF DIRECTORSALBERTA INNOVATES – HEALTH SOLUTIONS

ACCOUNTABILITY STATEMENT

[Original signed by Robert A. Seidel, QC]


The corporation’s home with Alberta Health and closer alignment to the health system means our collaborations, partnerships and investments are having real and beneficial effects on health and the health system. There is a “can-do” attitude that is bringing people and organizations together like never before to really advance and change how we do things for maximum value. Cy Frank’s vision was that the assets of our broad health system have the potential to yield more health and wealth than any other resource we have in Alberta. We are proud to do our utmost to make that vision a reality.

We serve the people of Alberta through several areas of focus. We seek and broker partnerships with other agencies, government departments, academia, the health system and industry to bring know-how from these sectors into approaches to solve health issues, and in doing so, we leverage the public dollars entrusted to us and maximize the impact of research results. With partners, we are leading the development of agreed-upon areas of core support for the entire health research and innovation system so that we see a much greater growth in capacity, resources and application of knowledge. The goal is to provide provincial research activities with the

strengths and supports to achieve greater national and global competitiveness and impact on health. We support highly rated health research activity and the innovations that result from that activity with the goal of better health and wellbeing for Albertans. We contribute to the intellectual capacity at our universities by funding top calibre people—from trainees to internationally acclaimed scientists—working in every area of health research.

The sum total of the year is impressive despite the blow of losing Dr. Frank. I commend the Board, the leadership team at AIHS and all of our staff for continuing to advance the corporation’s directions and maintain outstanding operations.

Robert A. Seidel, QCCHAIR, BOARD OF DIRECTORSALBERTA INNOVATES – HEALTH SOLUTIONS

MESSAGE FROM BOARD CHAIR

On behalf of the board of directors of Alberta Innovates – Health Solutions, I am very pleased to speak to our organization’s accomplishments and unwavering dedication to our strategic direction, especially in light of the tragic loss of our visionary president and CEO, Dr. Cy Frank, on March 5, 2015. Thanks to internal restructuring in late 2014 by Cy and his skilled management team, AIHS is in an optimal position to continue pursuing its goals: to deliver health, social and economic gains for Albertans from our support of health research and innovation.



To fulfill this mandate and to deliver on the 2014-17 Business Plan, AIHS focused on five goals:

• Strategic Investments• Platforms for Success• Relationship Development• Impact Evaluation and Acceleration• Building, Mobilizing and Accessing Capacity

In this section, we outline our key achievements for this year and some stories illustrating them. These achievements rely on people and organizations within the provincial environment working together towards a common goal – whether it be providing funding or collaborating with researchers in a different field or at a different institution or in a different country. AIHS investments in research and innovation usually involve multi-year commitments and it must be noted that many of the achievements highlighted here are the results of (sometimes) years of patience and diligence.

GOAL 1

Promote strategic research and innovative investments through the development of new programs and support of existing programs*

OUTCOMES

• Invest in collaborative, interdisciplinary, multi-sectoral, and/or multi-institutional research with a focus on achieving solutions that address complex health problems or issues through our Collaborative Research and Innovation Opportunities (CRIO) funding.

• Invest and support networks of health researchers and clinical practitioners across the continuum of care, with an emphasis on population health and community and primary care, which can reassess potentially inefficient activities within the health system and identify sustainable solutions to improve overall quality of care and value for money in the system. Funded by AIHS-Alberta Health Services Partnership for Research and Innovation in the Health System (PRIHS) awards.

• Invest in innovative, relevant, priority areas of cancer research, with investment in priority cancer prevention research from the Alberta Cancer Prevention Legacy Fund (ACPLF).

* please see Appendix A for a complete listing of current AIHS funding programs

KEY RESEARCH AND INNOVATION INITIATIVES

AIHS’s mandate is to support research and innovation which improves the health and wellbeing of Albertans and creates social, health and economic benefits for our province and its people.


KEY ACHIEVEMENTS

CRIO grants support collaborative research in priority areas for Alberta that engages knowledge-/end-users, produces new knowledge, and helps translate knowledge to improve health and the healthcare system. AIHS offers: CRIO Team, which can provide up to $5 million over 5 years to a large interdisciplinary team; CRIO Project which offers up to $2.5 million over 5 years to a group of three or more collaborators; and, CRIO Project which provides up to $750,000 over 3 years to collaborators focused on a defined project. AIHS invested $11.5M in existing CRIO grants during 2014-2015. A further $50.0M is committed to these multi-year grants over the next three years.

Performance Measure(s)Actual2013-14

Forecast2014-15

Actual2014-15

CRIO Investment $11.6M $18.0M $11.5M

PRIHS Investment $2.4M $5.0M $0.1M

ACPLF Investment $10.9M $14.0M $9.8M

** Investment values recognize the funds released during the period rather than the total value committed. Funds are released when authorized and eligibility criteria, if any, are met based on terms and conditions of the awards.

Funded in part by a CRIO Team grant, researchers completed an international randomized controlled trial showing that a clot retrieval procedure, known as endovascular treatment (ET), can dramatically improve patient outcomes after an acute ischemic stroke. The study, led by researchers at the University of Calgary’s Hotchkiss Brain Institute (HBI), shows a dramatic improvement in outcomes and a reduction in deaths from stroke. The results of this study were published in the February 11, 2015 online edition of the New England Journal of Medicine (NEJM). Overall, positive outcomes for patients increased from 30 per cent to 55 per cent. In many cases, instead of suffering major neurological disabilities, patients went home to resume their lives. The overall mortality rate was reduced from two in 10 patients for standard treatment of care to one in 10 patients – a 50 per cent reduction with ET. The senior author of the study was Dr Michael Hill, professor in the Cumming School of Medicine’s departments of clinical neurosciences, and radiology and a neurologist with the Calgary Stroke Program of Alberta Health Services (AHS). The study was funded by Alberta Innovates-Health Solutions, The Heart and Stroke Foundation of Canada, and Medtronic, along with generous donations to the HBI Stroke Team and the Calgary Stroke Program.


Funded by a CRIO Team grant, public health researchers Drs. Paul Veugelers and Arto Ohinmaa are evaluating several dozen health promotion strategies in Alberta to find out which are most effective in terms of health and economics. By the third year (2016/17) of the five-year project, researchers will have a good idea of what the province is spending money on and how each strategy measures up to a number of criteria, including mental health, learning, obesity and heart health. They’ll share their findings with policymakers. Information collected will help politicians make “fully informed decisions” about how the province invests in health promotion.

CRIO Population Resiliency - The Government of Alberta designated $50 million to support flood victims’ immediate and future mental health needs in the aftermath of the 2013 flooding in Southern Alberta. Three million dollars of that funding was allocated to an Alberta Health-AIHS partnership to establish the CRIO – Population Resiliency award. The Award focuses on developing and strengthening population resiliency before and after catastrophic events in two areas: aboriginal and child and youth populations. Two grant applications were successful:

Dr. Julie Drolet (University of Calgary), Dr. Robin Cox (Royal Roads University) and Dr. Caroline McDonald-Harker (Mount Royal University) are leading the 3-year Alberta Resilient Communities project (ARC) which works with children, youth and their communities to inform and strengthen child and youth mental health and enhance disaster preparedness, reduce risk and build resilience in Southern Alberta. ARC, a CRIO Program grant, will help better understand the social, economic, health, cultural, spiritual and personal factors that contribute to child and youth resiliency while empowering them, their families and communities to build resiliency.

A CRIO Team grant supports Prediction and Understanding of Resilience in Alberta Families: Longitudinal Study of Disaster Responses (PURLS). The leaders for this 3 year project are: Dr. Dawn Kingston (University of Alberta), Dr. Andrew Greenshaw (University of Alberta), Dr. Suzanne Tough (University of Calgary) and Dr. Sheila McDonald (Alberta Health Services).


The Partnership for Research and Innovation in the Health System (PRIHS) is a partnership between Alberta Innovates – Health Solutions (AIHS) and Alberta Health Services (AHS) aimed at improving health outcomes for patients across Alberta. This partnered funding opportunity targets high impact research activities within the AHS Strategic Clinical Networks (SCNs) that align with the priorities identified in the Alberta’s Health Research and Innovation Strategy (AHRIS) and the AHS Health Plan. PRIHS supports networks of health researchers and clinical practitioners across the continuum of care, with an emphasis on population health and community and primary care, that can reassess potentially inefficient activities within the health system and identify sustainable solutions to improve overall quality of care and value for money in the health system. Ten 2014 PRIHS grants, representing a total investment of approximately $7.2 million over three years, were approved and announced during the 2014/2015 year. A total of $12.4M is committed to PRIHS over the next three years, a grant jointly funded by AIHS and AHS.

In 2014/15, AIHS developed the Cancer Prevention Research Opportunity (CPRO), funded through the Alberta Cancer Prevention Legacy Fund (ACPLF) and part of the CRIO funding portfolio. Lowering rates of cancer and improving outcomes for cancer patients through prevention strategies and lifestyle change would be a major health, social and economic gain for everyone. To support that that goal, CPRO was designed to support research approaches that create new knowledge in the area of cancer prevention and screening and move that new knowledge and evidence into use in the health system, in communities, in workplaces, and in the daily lives of Albertans. CPRO grants will be awarded in 2015/16.

Funded by a 2013 AIHS PRIHS grant, Dr. Mary Forhan and her co-principal investigators Dr. Jeffrey Johnson and Dr. Arya Sharma collect data on the prevalence of obesity, length of stay and cost of care in adult cancer patients at the Cross Cancer Institute, cardiac surgery patients across Alberta, and children at the Glenrose Rehabilitation Hospital. The Diabetes, Obesity and Nutrition Strategic Clinical Network are also on board to help determine the longer hospital stays. One of the project’s goals includes developing best practice guidelines for providing quality care for rehabilitation patients who have obesity. The team will also survey healthcare providers about the gaps in training for the care of patients with obesity.


GOAL 2

Facilitate, develop and support platforms that address strategic outcomes and objectives

OUTCOMES

• Develop and implement the seven province-wide platforms of the Alberta SPOR SUPPORT Unit: Data Platforms and Service; Methods Support and Development; Health Systems Research, Implementation Research and Knowledge Translation; Pragmatic Clinical Trials; Career Development in Methods and Health Services Research; Consultation and Research Services; and Patient Engagement.

• Implement the Alberta Health Research Ethics Harmonization (HREH) initiative to achieve a streamlined, effective, collaborative and integrated health ethics model, supported by appropriate technology.

• Assess the requirements for Data Access and Platforms through partnerships and public engagement. Develop a Data and Data Analytics plan with inputs and support from the Provincial Health Analytics Network (PHAN), Alberta Health and Alberta Health Services.

KEY ACHIEVEMENTS

The Strategy for Patient-Oriented Research SUPPORT Unit is one way Alberta Innovates – Health Solutions and its partner, the Canadian Institutes for Health Research (CIHR), are supporting patient engagement research. The Unit is made up of seven platforms that offer researchers expertise and service in core areas such as data support and service, methods support and development and pragmatic clinical trials. Alberta’s SPOR SUPPORT unit platforms held a competition for the Leads positions of the seven platforms during the spring and summer of 2014, which resulted in the appointments of nine individuals as Leads or Joint leads. The platform Leads—alongside the Steering Committee and other partners—are working on the processes by which patient-oriented researchers can access the services, expertise and resources they need.

Significant work has been achieved with the HREH initiatives. The key areas of focus have been: governance, reciprocity, data sharing and common tools/processes. Under governance, the inaugural meeting of the HREH Steering Committee was held on December 1, 2014. The reciprocity agreement was signed by partners in 2014. Work on the implementation of the Institutional Research Information Services Solution (IRISS) platform continued to further support harmonized technical efforts. Lastly, AHS and Covenant Health have provided access to information which will help streamline research processes and reduce the amount of documentation required for submission.


Forecast2014-15

Actual2014-15

% Implementation of SPOR platforms 50% 50% 50%

% Implementation of HREH approach 75% 75% 75%


AIHS, in collaboration with partners, advanced the development of the provincial Data Analytics platform. Activities included the successful recruitment of a project manager for the platform; the scoping of a platform Project Charter and the formulation integrated secondary use data platform working groups.

Dr. Virginia Vandall-Walker is the lead for the Unit’s patient engagement platform. She is an Associate Professor in the Faculty of Health Disciplines graduate program at Athabasca University, and a member of the Canadian Association of Critical Care Nurses, the Canadian Council of Cardiovascular Nurses, and the International Family Nursing Association. Since patients and their families know best how their conditions affect them, they are the logical starting point for researchers in the development of meaningful research questions. If patients and family are involved from the outset, then researchers can be confident that the research questions investigated are ones that patients would like answered. While a patient-centered approach seems logical, in research initiatives it’s not as common as one would think. Dr. Vandall-Walker’s challenge is to find ways to help others understand the benefits of patient engagement.


GOAL 3

Engage and strengthen relationships and identify new relationships to achieve sustainable impact


Forecast2014-15

Actual2014-15

$ Attracted through partnerships (inc. partner administered funds)

$14.5M $10.0M $14.4M

# of stakeholder engagement initiatives 2 2 2

OUTCOMES

• Develop an AIHS Partnership Office and the related business plan.

• Create valuable stakeholder engagement and outreach initiatives including: SCN Connects, Engaging Experts event in June.

KEY ACHIEVEMENTS

In June, AIHS hosted a visit from Professor Dame Sally Davies, the Chief Medical Officer of the UK. Professor Davies met with the Premier, the Minister of Health, the AIHS Board, the Executive Team of AHS; the Executive Team of Alberta Health; representatives from the UA and from ARIA. Professor Davies also gave a public talk as part of The Health Policy Speakers Series jointly organized by AIHS and the Institute of Health Economics. Professor Davies shared her experiences in her role in guiding government decisions on all matters of public health, including such issues as superbugs, drug trials and obesity as well as the development of the National Institute for Health Research in 2006 with a budget of £1 billion.

The SCN Connects event at The Banff Centre attracted 250 participants from various stakeholder groups including policy makers, researchers, clinicians and patients. The keynote speaker was Brent James, who is known internationally for his work in clinical quality improvement, patient safety, and the infrastructure that underlies successful improvement efforts, such as culture change, data systems, payment methods, and management roles.

The International School on Research Impact Assessment (ISRIA) jointly hosted by AIH, AQuAS and Rand Europe was held for the first time in Alberta in September. The School provided an intense hands-on workshop for 60 participants to learn the tools and methodology for evaluating the impact of research funding and investment.


The AIHS Partnership Office was constituted during the organizational realignment in December 2014 and held its first meeting in January 2015. It is composed of executive-level representatives who have strong relationships with academia, industry and the health system. Until the passing of Dr Frank on March 5, it was chaired by the Chief Partnership Officer (who then took the role of Interim CEO). It is now chaired by the Vice President, Innovations and Initiatives. The Partnership Office works under a Terms of Reference and has developed a set of goals. The Programs and Projects business units were realigned into Innovations and Initiatives to ensure a clearer line of sight to the work of the Partnership Office.

GOAL 4

Accelerate and evaluate the impact of research and innovation in the system

OUTCOMES

• Develop a business plan for the Strategic Partnership to Accelerate Research and Innovation into Health Care. (SPARC)***.

• Influence the environment towards the use of assessment techniques and common tools, metrics, and processes used by AIHS and collaborators that impact strategic capacity funding initiatives, industrial collaborations, and programs for regional innovation.


Forecast2014-15

Actual2014-15

Complete business plan for SPARC n/a 100% 100%

KEY ACHIEVEMENTS

SPARC is a brand for a collaborative partnership focused on using research and innovation efforts to meet patient needs while delivering health, social and economic gains for Albertans. The guiding principle of SPARC is to integrate research and innovation to produce better solutions and to eliminate existing inefficiencies, with evidence and to meet current and new needs. The process behind SPARC is to co-identifiy, co-determine, co-develop and co-deliver solutions among HRIC partners. During 2014-2015, a plan for SPARC was developed and reviewed by HRIC. HRIC is the oversight body created to clarify roles and responsibilities, integrate and prioritize initiatives and find synergies between member organization on initiatives of health research and innovation in Alberta. The on-going activities of the HRIC enable the SPARC brand and process.


In conjunction with HRIC partners, AIHS assisted in the development of a common performance management framework for Alberta health research and innovation.

***SPARC members AIHS, Alberta Health, Innovation and Advanced Education, Alberta Health Services, the Academic Health Network (universities), community care providers (Alberta Medical Association) and Alberta Innovates – Technology Futures work together to build a research evidence-informed health system that meets the needs of all patients and realizes health, social and economic gains for Albertans.

AIHS is developing the “Implementing Health Research Impact Assessments: An Intensive Training Course” to be held in June 2015. This four day course targets building capacity in Alberta (and Canada) in health research impact assessment (HRIA) and provide a common language, approach and tools for the planning and implementation of HRIA.

GOAL 4

Build and mobilize capacity in the health research and innovation eco-system


Forecast2014-15

Actual2014-15

Funding for Trainees programs $9.9M $12.5M $9.0M

OUTCOMES

• Provide opportunities for trainees to gain broad experience within the health research environment to facilitate success in launching careers in academia, industry, government or elsewhere.

KEY ACHIEVEMENTS

AIHS provided support to a wide range of trainees – from Grade 11 students working in Alberta’s universities’ labs in the summer to postgraduate fellows working towards their first appointment in academia or beyond.

New in 2014/15

Total # Supported by AIHS as at March 31, 2015

HYRS students 50 0

Summer Students 163 0

Media Fellowship 2 0

Graduate Studentships 38 130

Post graduate fellows 37 68

MD/PhD 3 20

Clinician Fellowships 10 34


The PLUS Option is a component of the Graduate Studentship award that provides trainees with the opportunity to gain valuable experience and additional skills beyond those acquired through their direct graduate research training. Up to one year of additional support may be requested for the PLUS Option, to be utilized at any point during the tenure of the award or up to six months following the award completion. Trainees can utilize the opportunity to seek training or internship opportunities in business, education, industry, government and/or health policy, within clinical or other health research related environments.

The PLUS Option was initiated several years ago, and as expected students are waiting until the end of the award to apply for this Option. To date, AIHS has received 11 applications. Six are implemented and five are under review. Two PLUS Option awards were made in 2014-15.

Tamara Germani is an AIHS clinician fellow completing a PhD in pediatrics. She is working on a research project which looks at how preschoolers with autism get along with others. In the first part of the project, Germani is surveying families, educators and clinicians (including occupational therapists, physicians and psychologists) from across Canada. Next, she will help develop a new classification system to identify children’s skills (such as playing with or beside another child, sharing toys and talking with others), then ask caregivers dealing with autism to comment on the system. When working as an occupational therapist helping children with autism spectrum disorder (ASD) relate to other kids, she noticed parents and teachers tended to focus on what kids couldn’t do—rather than what they could. She hopes that her research project will help provide a snapshot of a child’s abilities that caregivers can tap into and help promote more positive awareness from the children themselves.

Perla Cota-Elizondo has a one year term with Resverlogix, a biotechnology company that develops drugs for cardiovascular disease, based in Calgary and San Francisco. Perla works with the business development team, which is in charge of the bridging science and business teams within the company. The opportunity will provide her with mentorship and develop her skills in researching competitive intelligence, grant writing, required reporting and business development.

Lauren Killip has a one year term with Focal Healthcare Inc. as a Business Development Manager. Focal Healthcare Inc. based in Toronto, is developing a medical device for the diagnosis and treatment of prostate cancer. Lauren will gain mentorship, business and industry experience that will expand her skills sets beyond those attained from her graduate research training.


FINANCIAL POSITION

The Statement of Financial Position shows net assets of $48.6 million and cash of $95.2 million. AIHS has $184.7 million of contractual obligations over the next five years (see note 13) which will become liabilities in future periods. The growing net assets balance reflects the increasing future year commitments that are not yet recognized as liabilities. Cash of $95.2 million includes restricted cash of $38.1 million. The restricted cash reflects payments received for a specified purpose. Funds are recorded as restricted cash and deferred revenue until the resources are used for the purpose specified. Higher unrestricted cash balances reflect the delayed timing of the implementation of new programs, platforms and initiatives where commitments have been made, however the activity to recognize the liability will take place in a later period.

REVENUE

Operating and unrestricted grants are recognized as revenue in the year the transfers are received or receivable. Externally restricted revenue, including partnership revenue, is recognized as revenue in the period in which the resources are used for the purpose specified.

Cash received from Government of Alberta Grants was as budgeted. However, as a portion of the received restricted funds for ACPLF were not expended during the period, the revenue recognized was $3.9 million lower than budgeted and the balance was recorded as deferred revenue.

Partnership revenue was $4.3 million lower than budget as the cash was received but revenue was deferred as the associated program spending was delayed into 2015-2016.

Investment income is interested income generated by the Consolidated Cash Investment Trust Fund. The higher than budgeted cash balance generated higher than budgeted interest during the year.

MANAGEMENT’S DISCUSSION AND ANALYSIS

The results presented in AIHS’s audited financial statements are shaped by our mandate from the Government of Alberta: to provide leadership for Alberta’s health research and innovation enterprise by directing, coordinating, reviewing, funding and supporting priority health research and innovation activities.

AIHS’s investments are targeted to the following outcomes: development and growth of the health sectors, the discovery of new knowledge, and the application of that knowledge to improve the health and wellbeing of Albertans. The major focus of AIHS’s activity is on making quality investments relevant to system needs and priorities.


EXPENDITURES

• Strategic investments includes Alberta Heritage Foundation for Medical Research (AHFMR) Legacy programs, the Collaborative Research and Innovation Opportunities (CRIO) portfolio, Translational Health Chairs as well as funding for new strategic opportunities. Timing of the implementation and awarding of new funding opportunities, as well as continued support of legacy programs, resulted in a timing delay of $13.0 million as compared to budget.

• Platforms for Success expenses include SPOR Support unit funding as well as other platform spending such as the Ethics Innovations initiatives. Actual spending was $12.4 million lower than budgeted, $10.5 million of which related to the timing of SPOR implementation.

• Relationship Development expenses include stakeholder engagement activities and the administration of partner restricted funds. Expenses were $13.5 million lower than budgeted as the development of programs delayed the recognition of commitments to liabilities with partner funds until 2015-2016.

• Expenditures related to Impact Evaluation and Acceleration were $0.2 million lower than budgeted as a result of delayed timing of Knowledge Translation initiatives.

• Building Capacity expenditures of education and career development awards as well as platform development costs were $3.9 million lower than planned due to timing of development awards.

• Emerging opportunities of $9.8 million were budgeted but were deferred until 2015-2016.

• Operations expenses were $1.1 million lower than budget. Lower salaries and benefits as a result of vacant positions combined with lower spending on supplies and services, resulted in the positive variance.

COMMITTED FUNDING

AIHS committed funding is money allocated over a time period for a specific purpose. In some cases, AIHS receives cash through partnerships which require corresponding funding from AIHS. To recognize the expense the grant must be approved, all eligibility criteria met, and the expense unavoidable. In other cases, funding is allocated to AIHS for the purposes of fulfilling an agreement approved by AIHS Board of Directors. The supplemental draw on the AHFMR Endowment is an example of an annual allocation of funding to AIHS from the government to help the provinces universities manage the transition of researchers from the Legacy funding program, retain outstanding talent and sustain research capacity and strength.


During 2014-15, AIHS operated the following core platforms, partnerships and initiatives:

• Partnership Office• SPOR SUPPORT Unit• Strategic Provincial Partnership for Accelerating

Health Research and Innovation in Care platforms• Collaborative Research and Innovation

Opportunities (CRIO): Projects, Programs and Teams

• Partnership for Research and Innovation in the Health System (PRIHS)

• Early Career Development and Training Programs• Translational Health Chairs• Industry Partnered Translation Fund• Independent Investigator Awards• Cancer Research grants and awards as supported

through the Alberta Cancer Prevention Legacy Fund

• Ethics & Innovation Initiatives• Performance Management and Evaluation

In late 2014, AIHS realigned its organization structure in order to better support the organization’s new focus on partnerships and catalyzing provincial platform development. We created the Partnership Office and the Provincial Platforms & SPOR business unit. Members of the leadership team were reassigned in order to reflect these operational priorities. In March, further adjustments were made to the organizational structure following the passing of Dr. Frank – most notably, Dr. Pamela Valentine was named Interim CEO and Mr. Reg Joseph was assigned as Chair of the Partnership Office.

AIHS governance remained stable throughout the year. There were no changes to the bylaws, code of conduct, conflict of interest policies or intellectual property practices during the year. The organization continues to follow guidance provided by the Government of Alberta on appropriate policies and procedures for transparency and accountability.

Grants received from the Government of Alberta totaled $98 million: the annual base grant of $86 million from Alberta Health and $12.5 from the ACPLF, also from Alberta Health. An additional $5.5 million was from partnership and investment revenues. Total expenses were $87.6 million, resulting in net operating surplus of $12.7 million.

OPERATIONAL OVERVIEW


Alberta Innovates – Health Solutions

CONSOLIDATED FINANCIAL STATEMENTSMARCH 31, 2015

Management’s Responsibilities for the Financial Statements

Independent Auditor’s Report

Consolidated Statement of Financial Position

Consolidated Statement of Operations

Consolidated Statement of Cash Flows

Notes to the Consolidated Financial Statements

Schedule 1 – Expenses Detailed by Object

Schedule 2 – Salary and Benefits Disclosure

Schedule 3 – Related Party Transactions

Schedule 4 – Budget Reconciliation


The accompanying financial statements are the responsibility of management and have been reviewed and approved by Senior Management. The financial statements were prepared in accordance with Canadian Public Sector Accounting Standards, and of necessity, include some amounts that are based on estimates and judgement.

To discharge its responsibility for the integrity and objectivity of financial reporting, management maintains a system of internal accounting controls comprising written policies, standards and procedures, a formal authorization structure, and satisfactory processes for reviewing internal controls. This system provides management with reasonable assurance that transactions are in accordance with governing legislation and are properly authorized, reliable financial records are maintained, and assets are adequately safeguarded.

Dr. Pamela ValentineINTERIM CEO

ALBERTA INNOVATES – HEALTH SOLUTIONS

MANAGEMENT’S RESPONSIBILITY FOR REPORTING

Alberta Innovates Health Solutions Board of Directors carries out their responsibility for the financial statements through the Finance and Audit Committee. The Committee meets with management and the Auditor General of Alberta to review financial matters, and recommends the financial statements to Alberta Innovates Health Solutions Board of Directors for approval upon finalization of the audit. The Auditor General of Alberta has free access to the Finance and Audit Committee.

The Auditor General of Alberta provides an independent audit of the financial statements. His examination is conducted in accordance with Canadian Generally Accepted Auditing Standards and includes tests and procedures, which allow him to report on the fairness of the financial statements prepared by management.

Maureen FromhartVICE PRESIDENT, CORPORATE SERVICES

ALBERTA INNOVATES – HEALTH SOLUTIONS

May 27, 2015

[Original signed by Pamela Valentine, PhD] [Original signed by Maureen Fromhart, CMA]


Independent Auditor’s Report

To the Board of Directors of Alberta Innovates—Health Solutions

Report on the Consolidated Financial StatementsI have audited the accompanying consolidated financial statements of Alberta Innovates—Health Solutions, whichcomprise the consolidated statement of financial position as at March 31, 2015, and the consolidated statements ofoperations and cash flows for the year then ended, and a summary of significant accounting policies and otherexplanatory information.

Management’s responsibility for the Consolidated Financial StatementsManagement is responsible for the preparation and fair presentation of these consolidated financial statements inaccordance with Canadian public sector accounting standards, and for such internal control as managementdetermines is necessary to enable the preparation of consolidated financial statements that are free from materialmisstatement, whether due to fraud or error.

Auditor’s ResponsibilityMy responsibility is to express an opinion on these consolidated financial statements based on our audit. Iconducted my audit in accordance with Canadian generally accepted auditing standards. Those standards requirethat I comply with ethical requirements and plan and perform the audit to obtain reasonable assurance aboutwhether the consolidated financial statements are free from material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in theconsolidated financial statements. The procedures selected depend on the auditor’s judgment, including theassessment of the risks of material misstatement of the consolidated financial statements, whether due to fraud orerror. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparationand fair presentation of the consolidated financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internalcontrol. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness ofaccounting estimates made by management, as well as evaluating the overall presentation of the consolidatedfinancial statements.

I believe that the audit evidence I have obtained is sufficient and appropriate to provide a basis for my audit opinion.

OpinionIn my opinion, the consolidated financial statements present fairly, in all material respects, the financial position ofAlberta Innovates—Health Solutions as at March 31, 2015, and the results of its operations, its remeasurementgains and losses, and its cash flows for the year then ended in accordance with Canadian public sector accountingstandards.

[Original signed by Merwan N. Saher, FCA]

Auditor General

May 27, 2015

Edmonton, Alberta


ALBERTA INNOVATES - HEALTH SOLUTIONSCONSOLIDATED STATEMENT OF FINANCIAL POSITIONAS AT MARCH 31, 2015

2015 2014(in thousands)

AssetsCash (Note 6) $ 95,245 $ 62,573 Accounts Receivable and Other Assets (Note 8) 950 8,527Tangible Capital Assets (Note 9) 841 943

$ 97,036 $ 72,043

LiabilitiesAccounts Payable and Accrued Liabilities (Note 10) $ 9,421 $ 11,971Deferred Revenue (Note 11) 38,687 23,763Benefit Plans (Note 12(b)) 328 378

$ 48,436 $ 36,112

Net AssetsAccumulated Operating Surplus 48,600 35,931

$ 97,036 $ 72,043

Contractual Obligations (Note 13)

The accompanying notes and schedules are a part of these consolidated financial statements.

Approved by:

Robert Seidel, Q.C.Board of Directors, Chair

Dr. Aubrey TingleFinance and Audit Committee, Chair

Dr. Aubrey TingleFINANCE AND AUDIT COMMITTEE, CHAIR

Robert Seidel, Q.C.BOARD OF DIRECTORS, CHAIR

[Original signed by Aubrey Tingle, MD, PhD, FRCPC, FCAHS]



ALBERTA INNOVATES - HEALTH SOLUTIONSCONSOLIDATED STATEMENT OF OPERATIONSYEAR ENDED MARCH 31, 2015

2015 2014Budget

(Schedule 4)Actual Actual

(in thousands)Revenues

Government TransfersGovernment of Alberta Grants $ 101,794 97,932 100,363

Partnership Revenue 4,797 500 1,257Other Revenue 984 933 1,054Investment Income 450 882 593

108,025 100,247 103,267

Expenses (Schedule 1 and Note 2(b)(iii))

Strategic Investment 69,309 56,271 75,080Platforms for Success 18,823 6,465 4,313Relationship Development 16,187 2,698 4,299 Impact Evaluation and Acceleration 2,275 2,118 1,418Building Capacity 13,850 9,901 10,865Emerging Opportunities 9,750 - -Operations 11,266 10,125 9,298

141,460 87,578 105,273

Annual Operating Surplus (Deficit) $ (33,435) $ 12,669 $ (2,006)

Accumulated Surplus, Beginning of year 35,931 37,937Accumulated Surplus, End of year 48,600 35,931



ALBERTA INNOVATES - HEALTH SOLUTIONSCONSOLIDATED STATEMENT OF CASH FLOWSYEAR ENDED MARCH 31, 2015

2015 2014(in thousands)

Operating TransactionsAnnual Operating Surplus (Deficit) $ 12,669 $ (2,006)Non-Cash Items:

Amortization of Tangible Capital Assets (Note 9) 269 223Loss on Disposal of Tangible Capital Assets - 24Deferred Revenue Recognized as Revenue (12,046) (15,230)

892 (16,989)

(Decrease) Increase in Accounts Receivable and Other Assets 7,577 (4,534)Decrease (Increase) in Accounts Payable and Accrued Liabilities (2,550) 10,205Increase in Deferred Revenue Received/Receivable 26,970 28,768Decrease in Benefit Plans (50) (50)Cash Provided by Operating Transactions 32,839 17,400

Capital TransactionsPurchase of Tangible Capital Assets (Note 9) (167) (102)Cash Applied to Capital Transactions (167) (102)

Increase in Cash 32,672 17,298Cash, Beginning of Year 62,573 45,275Cash, End of Year $ 95,245 $ 62,573



ALBERTA INNOVATES – HEALTH SOLUTIONSNOTES TO THE CONSOLIDATED FINANCIAL STATEMENTSMARCH 31, 2015

NOTE 1 AUTHORITY AND PURPOSE

Alberta Innovates – Health Solutions (the Corporation) is a Provincial Corporation, as defined in the Financial Administration Act, that was established on January 1, 2010 and operates under the authority of the Alberta Research and Innovation Act.The mandate of the Corporation is to support the economic and social well-being of Albertans, health research and innovation activities that are aligned to meet Government of Alberta priorities, including, without limitation, activities directed at the development and growth of the health sector, the discovery of new knowledge and the application of that knowledge.

The Corporation is exempt from income taxes under the Income Tax Act.

NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

These consolidated financial statements are prepared in accordance with Canadian public sector accounting standards (PSAS).

a) Reporting Entity and Method of Consolidation

The consolidated financial statements reflect the assets, liabilities, revenues andexpenses of the reporting entity, which is comprised of the Corporation and theAlberta Foundation for Health Research (AFHR). The AFHR operates under theAlberta Companies Act and is a registered charitable organization for income taxpurposes. The Foundation’s activities are directed to promote and supportmedical research. All intercompany balances and transactions have beeneliminated on consolidation.

b) Basis of Financial Reporting

(i) Revenue RecognitionAll revenues are reported on the accrual basis of accounting. Cash received forwhich goods or services have not been provided by year end is recorded asdeferred revenue. Externally restricted revenue, including partnership revenue,is recognized as revenue in the period in which the resources are used for thepurpose specified. Funds received prior to meeting the criterion are recorded asdeferred revenue until the resources are used for the purpose specified.

Operating and unrestricted grants are recognized as revenue in the year thetransfers are received or receivable. Restricted grants are included in deferredrevenue when received, and recognized as revenue when the Corporation meetsthe conditions of the grant.



SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont’d)

Investment income includes interest recorded on the accrual basis where there is reasonable assurance as to its measurement and collection.

(ii) Government transfersTransfers from the Government of Alberta, other governments, and othergovernment entities are referred to as government transfers.

Government transfers and the associated externally restricted investment incomeare recorded as deferred revenue if the terms for use of the transfer, or the termsalong with the Corporation’s actions and communications as to the use of thetransfer, create a liability. These transfers are recognized as revenue as theterms are met and, when applicable, the Corporation complies with itscommunicated use of the transfer.

All other government transfers, without terms for use of the transfer, arerecorded as revenue when the transfer is authorized and the Corporation meetsthe eligibility criteria.

(iii) ExpensesExpenses are reported on an accrual basis. The cost of all goods consumed andservices received during the year are expensed.

Directly incurred expenses are costs the Corporation has primary responsibilityand accountability for. In addition to operating expenses such as salaries andsupplies, directly incurred expenses also include:

• Amortization of tangible capital assets.• Pension costs which comprise of the cost of employer contributions for

current service of employees during the year.• Valuation adjustments which include changes in the valuation

allowances used to reflect financial assets at their net recoverable orother appropriate value. Valuation adjustments also represent the changein management’s estimate of future payments arising from obligationsrelating to vacation pay.

Grants are recognized as expenses when authorized, eligibility criteria, if any,are met, and a reasonable estimate of the amounts can be made.




(iv) AssetsFinancial AssetsFinancial assets are assets that could be used to discharge existing liabilities orfinance future operations and are not for consumption in the normal course ofoperations. Financial assets of the Corporation are limited to financial claims,such as advances to and receivables from other organizations, employees andother individuals.

The Consolidated Cash Investment Trust Fund (CCITF) is managed with theobjective of providing competitive interest income to depositors whilemaintaining appropriate security and liquidity of depositors’ capital. Theportfolio is comprised of high-quality, short-term and mid-term fixed incomesecurities with a maximum to maturity of three years.

Tangible Capital AssetsTangible capital assets of the Corporation are recorded at historical cost, whichincludes amounts that are directly related to the acquisition, design,construction, development, improvement, or betterment of the assets. Tangiblecapital assets are amortized on a straight-line basis over the estimated usefullives of the assets.

Tangible capital assets are written down when conditions indicate that they nolonger contribute to the Corporation’s ability to provide services or when thevalue of future economic benefits associated with the tangible capital assets areless than their net book value.

(v) Net AssetsNet assets represent the difference between the carrying value of assets held bythe Corporation and its liabilities.

Canadian public sector accounting standards require a “net debt” presentationfor the statement of financial position in the summary financial statements ofgovernments. Net debt presentation reports the difference between financialassets and liabilities as “net debt” or “net financial assets” as an indicator of thefuture revenues required to pay for past transactions and events. TheCorporation operates within the government reporting entity, and does notfinance all its expenditures by independently raising revenues. Accordingly,these financial statements do not report a net debt indicator.




(vi) LiabilitiesLiabilities are recorded to the extent that they represent present obligations as aresult of events and transactions occurring prior to the end of fiscal year. Thesettlement of liabilities will result in sacrifice of economic benefits in the future.

(vii) Employee Future BenefitsThe Corporation operates a defined contribution pension plan. Pension costsincluded in these consolidated financial statements are comprised of the cost ofemployer contributions for the current service of employees during the year.There are no unfunded liabilities with respect to pension and pension costs.

(viii) Valuation of Financial Assets and LiabilitiesThe Corporation’s financial assets and liabilities are generally measured asfollows:

Financial Statement Component MeasurementCash Amortized cost Accounts receivable and other assets Amortized cost Accounts payable and accrued liabilities Amortized cost

The Corporation has no assets or liabilities in the fair value category, has not engaged in foreign currency transactions and has no remeasurement gains or losses. Consequently, no statement of remeasurement gains or losses has been presented.

For financial instruments measured using amortized cost, the effective interest rate method is used to determine interest revenue or expense. Transaction costs are a component of cost for financial instruments measured using cost or amortized cost. Transaction costs are expected for financial instruments measured at fair value.

(ix) Measurement uncertaintyThe measurement of certain assets and liabilities is contingent upon futureevents; therefore, the preparation of these consolidated financial statements requires the use of estimates, which may vary from actual results. Management uses judgment to determine such estimates. In management’s opinion, the resulting estimates are within reasonable limits of materiality and are in accordance with the significant accounting policies summarized below.



NOTE 3 CHANGE IN ACCOUNTING POLICY

In June 2010 the Public Sector Accounting Board (PSAB) issued this accounting standard effective for fiscal years starting on or after April 1, 2014. Contaminated sites are a result of contamination being introduced into air, soil, water or sediment of a chemical, organic or radioactive material or live organism that exceeds an environmental standard. The Corporation adopted this accounting standard retroactively as of April 1, 2014 but without restatement of prior period results. The Corporation is required to recognize a liability related to the remediation of such contaminated sites subject to certain recognition criteria. For the fiscal year ended March 31, 2015, The Corporation has not identified any liability for contaminated sites.

NOTE 4 Future Accounting Changes

Future Accounting Changes In March 2015 the Public Sector Accounting Board issued PS 2200 – Related party disclosures and PS 3420 – Inter-entity transactions. These accounting standards are effective for fiscal years starting on or after April 1, 2017.

PS 2200 – Related party disclosures defines a related party and identifies disclosures for related parties and related party transactions, including key management personnel and close family members.

PS 3420 – Inter-entity transactions, establishes standards on how to account for and report transactions between public sector entities that comprise a government’s reporting entity from both a provider and recipient perspective.

Management is currently assessing the impact of these statements on the financial statements.

NOTE 5 BUDGET(in thousands)

A preliminary business plan with a budgeted deficit of $33,435 was approved by the Board on March 27, 2014 and the full financial plan was submitted to the Minister of Health. The budget reported in the statement of operations reflects the original $33,435 deficit.



NOTE 6 CASH(in thousands)

Cash in the amount of $95,245 (2014 - $62,573) include deposits in the Consolidated Cash Investment Trust Fund (CCITF) amounting to $95,096 (2014 - $62,451). Cash as at March 31, 2015 includes restricted cash of $38,137 (2014 - $15,730). As at March 31, 2015, securities held by the Corporation have a return of 1.2% per annum (2014: 1.2% per annum). Due to the short-term nature of CCITF investments, the carrying value approximates fair value.

NOTE 7 FINANCIAL RISK MANAGEMENT

The Corporation’s financial instruments include cash, accounts receivable and other assets and accounts payable and accrued liabilities. The Corporation is not involved in any hedging relationships through its operations and does not hold or use any derivative financial instruments for trading purposes.

The Corporation’s financial instruments are exposed to credit risk, market risk and liquidity risk.

a) Credit RiskCounterparty credit risk is the risk of loss arising from the failure of a counterpartyto fully honour its financial obligations with the corporation. The Corporation’saccounts receivable are exposed to credit risk. Management manages this risk bycontinually monitoring the creditworthiness of counterparties and by dealing withcounterparties that it believes are creditworthy.

b) Market RiskMarket risk is the risk of loss from unfavourable change in fair value or future cashflows of a financial instruments causing financial loss. Market risk is comprised ofcurrency risk, interest rate risk and price risk. The Corporation’s cash is exposed tointerest rate risk. Management manages this risk by continually monitoring theCorporation’s deposits in the CCITF and their corresponding rate of return.

c) Liquidity RiskLiquidity risk is the risk that the Corporation will encounter difficulty in meetingobligations associated with its financial liabilities. The Corporation’s accountspayable and accrued liabilities are exposed to liquidity risk. Management managesthis risk by continually monitoring cash flows.



NOTE 8 ACCOUNTS RECEIVABLE AND OTHER ASSETS (in thousands)

2015 2014Gross

AmountAllowance for

Doubtful Accounts

Net Realizable

Value

Net Realizable

Value

Accounts Receivable $ 651 $ - $ 651 $ 8,422Other Receivables 299 - 299 105

$ 950 $ - $ 950 $ 8,527

Accounts receivable are unsecured, non-interest bearing and reported at their net realizable value.



NOTE 9 TANGIBLE CAPITAL ASSETS (in thousands)

2015 2014

Equipment

Computer hardware

& software (c)

Leasehold improvements

(b)Total Total

Estimated Useful Life 5-10 years 3 years

Historical Cost (a)

Beginning of Year $ 444 $ 1,851 $ 838 $ 3,133 $ 3,272Additions 11 106 50 167 102Disposals - (2) - (2) (241)

$ 455 $ 1,955 $ 888 $ 3,298 $ 3,133

Accumulated AmortizationBeginning of year $ 346 $ 1,094 $ 750 $ 2,190 $ 2,184Amortization expense 12 214 43 269 223Effect of disposals - (2) - (2) (217)

$ 358 $ 1306 $ 793 $ 2,457 $ 2,190Net Book Value at March 31, 2015 $ 97 $ 649 $ 95 $ 841

Net Book Value at March 31, 2014 $ 98 $ 757 $ 88 $ 943

(a) Equipment includes office equipment and furniture, and other equipment.(b) Leasehold improvements are amortized over the lease term.(c) Historical cost includes computer hardware and software work-in-progress at March 31, 2015 totaling $31 (2014 -

$399)

NOTE 10 ACCOUNTS PAYABLE AND ACCRUED LIABILITIES(in thousands)

2015 2014Accounts Payable and Accrued Liabilities $ 9,270 $ 11,718Other 151 253

$ 9,421 $ 11,971



NOTE 11 DEFERRED REVENUE(in thousands)

2015 2014Government of Alberta

Federal Government

Non-Government Total Total

Balance, beginning of year $ 19,958 2,912 893 $ 23,763 $ 10,225Received/receivable during year 21,404 4,947 500 26,851 28,696Restricted realized investment income 119 - - 119 72

Less amounts recognized as revenue (11,546) (250) (250) (12,046) (15,230)Balance, end of year $ 29,935 7,609 1,143 $ 38,687 $ 23,763

NOTE 12 BENEFIT PLANS (in thousands)

(a) Pension Plan

The Corporation participates in a Defined Contribution Pension Plan pension. Theexpense for this pension plan is $445 (2014 - $357). AIHS accounts for this plan ona defined contribution basis.

(b) Accrued Retirement Allowance

The Benefit Plans consists of the unfunded liability for the Corporation’ssupplemental retirement plan, the benefits under which are paid for entirely by theCorporation when they come due. There are no plan assets. There are no activemembers remaining in the plan and two retired members eligible for benefits.

At March 31, 2015 these plans have net accrued liability of $328 (2014 - $378).

2015 2014Benefit Plans – Beginning of year $ 378 $ 428Interest cost 3 3Benefits paid (53) (53)Benefit Plans – End of year $ 328 $ 378



NOTE 13 CONTRACTUAL OBLIGATIONS(in thousands)

Contractual obligations are obligations of the Corporation to others that will become liabilities in the future when the terms of those contracts or agreements are met.

2015 2014Obligations under grants and awards and office premises $ 184,746 $ 205,624

Estimated payment requirements for each of the next five years and thereafter are as follows:

(a) Grants and awards are recorded as commitments when all terms and conditions have been agreedto but eligibility criteria have not been met.

(b) The Corporation has entered into a 104 month lease for office premises. The lease was re-negotiated on January 29, 2014 and expires on September 30, 2022.

NOTE 14 APPROVAL OF FINANCIAL STATEMENTS

These consolidated financial statements were approved by the Board of Directors.

Grants and Awards (a) Office Premises (b) Total

2015-16 $ 69,188 $ 601 $ 69,7892016-17 45,894 682 46,5762017-18 37,974 706 38,6802018-19 24,471 698 25,1692019-20 1,789 698 2,487Thereafter 300 1,745 2,045

$ 179,616 $ 5,130 $ 184,746


ALBERTA INNOVATES - HEALTH SOLUTIONSSchedule 1Expenses - Detailed by ObjectFor the Year Ended March 31, 2015(in thousands)

2015 2015 2014Budget Actual Actual

Grants $ 124,540 $ 74,021 $ 93,598 Supplies & Services 9,573 7,043 6,086Salaries, Wages & Employee Benefits 6,972 6,245 5,342Amortization of Tangible Capital Assets 375 269 223Loss on Disposal of Tangible Capital Assets - - 24

$ 141,460 $ 87,578 $105,273


ALBERTA INNOVATES - HEALTH SOLUTIONSSchedule 2Salary and Benefits DisclosureFor the Year Ended March 31, 2015(in thousands)

2015 2014

Base Salary (1)

Other Cash

Benefits (2)

Other Non-Cash Benefits

(3) Total Total

Chair of the Board $ - $ - $ - $ - $ 0

Board Members - 25 - 23 26

Chief Executive Officer (4) 340 - 46 386 414

Chief Partnership Officer (5) 258 - 55 313 279

Executive/Vice Presidents:

Vice President - Corporate Services (6) 192 - 32 224 133Vice President – Initiatives and

Innovations (7) 171 - 43 214 51Vice President – Provincial Platforms &

SPOR (8) 63 - 19 82 -

Strategic Advisor, CEO (9) 76 - 27 103 -

(1) Base salary includes regular salary.(2) Other cash benefits include earnings such as honoraria.(3) Other non-cash benefits include employer’s share of all employee benefits and contributions or payments made on behalf of employees

including pension, supplementary retirement plan, health care, dental coverage, group life insurance, short and long term disabilityplans and professional memberships.

(4) On March 5, 2015 the Chief Partnership Officer was named interim Chief Executive Officer after the Chief Executive Office passedaway.

(5) The Chief Operating Officer position was reclassified as Chief Partnership Officer in the fiscal year.

(6) The Vice President – Corporate Services position was vacant from March 15, 2013 to August 12, 2013.

(7) The Vice President – Health Technologies position was reclassified as Vice President – Initiatives and Innovations in the fiscal year.

(8) The Vice President – Provincial Platforms & SPOR is a new position that was filled on January 5, 2015.

(9) The Strategic Advisor, CEO is a new position that was filled on July 1, 2014.


ALBERTA INNOVATES - HEALTH SOLUTIONSSchedule 3Related Party TransactionsFor the Year Ended March 31, 2015

Related parties are those entities consolidated or accounted for on a modified equity basis in the Government of Alberta's financial statements. Related parties also include key management personnel in the corporation. The corporation and its employees paid of collected certain taxes and fees set by regulation for premiums, licenses and other charges. These amounts were incurred in the normal course of business, reflect changes applicable to all users, and have been excluded from this Schedule.

The Corporation had the following transactions with related parties which are recorded on the Consolidated Statement of Operations and the Consolidated Statement of Financial Position at the amount of consideration agreed upon between the related parties.

(in thousands)

Entities in the MinistryOther Entities Outside of the

Ministry2015 2014 2015 2014

RevenuesGrants $ 97,113 $ 100,363 $ 819 $ -Other Revenue 156 71 7 4

$ 97,269 $ 100,434 $ 826 $ 4

Expenses – Directly IncurredGrants $ 3,062 $ 4,085 $ 69,063 $ 87,309Other Services 192 58 692 867

$ 3,254 $ 4,143 $ 69,755 $ 88,176

Receivables from $ 45 $ 6,845 $ 524 $ 1,074

Payables to $ 153 $ 549 $ 7,883 $ 9,860

Deferred Revenue $ 27,004 $ 17,208 $ 2,931 $ 2,750

Contractual obligations $ 6,375 $ 6,237 $ 172,719 $ 192,799


ALBERTA INNOVATES - HEALTH SOLUTIONSSchedule 4BudgetFor the Year Ended March 31, 2015

Original Budget Reclassifications Budget

(in thousands)Revenues

Government TransfersGovernment of Alberta Grants $ 101,794 $ - $ 101,794

Partnership Revenue 4,797 - 4,797Other Revenue (1) 1,434 (450) 984Investment Income (1) - 450 450

108,025 - 108,025

Expenses (2)

Strategic Investment 73,154 (3,845) 69,309Platforms for Success 16,123 2,700 18,823Relationship Development 16,817 (630) 16,187Impact Evaluation and Acceleration 1,850 425 2,275Building Capacity 12,500 1,350 13,850Emerging Opportunities 9,750 - 9,750Operating / Administrative Costs 11,266 - 11,266

141,460 - 141,460

Annual operating surplus (deficit) $ (33,435) $ - $ (33,435)

(1) Interest Income was included in Other Revenue and has been reclassified to Investment Income.(2) ACPLF expenses reallocated to other key initiatives.


APPENDIX A:AIHS FUNDING AWARDS

We support collaborative research in priority areas for Alberta that engages knowledge-/end-users, produces new knowledge, and helps translate knowledge to improve health and the healthcare system.

CRIO ProjectsAllows a small group of interdisciplinary collaborators (minimum three) to come together with knowledge- and/or end-users to complete a defined health research project with defined deliverables. Up to $250,000 per year for up to 3 years.

CRIO ProgramsEnables a group of interdisciplinary collaborators (three or more) who may already work together to focus on a complex program of health research and innovation that addresses health research needs, gaps or opportunities. The research program must engage knowledge- and/or end-users to encourage uptake of evidence and must be aligned to priority areas of health for Albertans. Up to $500,000 per year for 5 years.

CRIO TeamsEnables a large, interdisciplinary team or network of researchers with national or international stature to tackle health issues involving many stakeholder groups. The team must have an experienced leader identified. The research activities must engage knowledge- and/or end-users to encourage uptake of evidence and must be aligned to priority areas of health for Albertans. Up to $1,000,000 per year for up to 5 years.

CRIO – Cancer Prevention Research Opportunity (CPRO)Enables a group of interdisciplinary individuals working in cancer prevention research to use a collaborative approach in the creation of new knowledge in cancer prevention and screening and moving knowledge and evidence into use in the health system, in communities and workplaces and in the daily lives of Albertans. Maximum of 5 years. Funding level will vary depending upon research scope and amount applied for (Level 1, 2 or 3):

• Level 1 (up to $250,000 per year)• Level 2 (up to $500,000 per year)• Level 3 (up to $1,000,000 per year)

CRIO – Population ResiliencyEnables a group of interdisciplinary collaborators to focus on either (or both) of two areas of population resiliency: aboriginal populations and child and youth. Using a collaborative approach to the production of new knowledge, coupled with the translation of research findings to knowledge- or end-users for impact on the health of Albertans and/or the health system. Award funding will vary depending upon the level of research being applied for (Project, Program or Team).

HEALTH RESEARCH & INNOVATION SUPPORT

Collaborative Research and Innovation Opportunities (CRIO) funding suite


Partnership for Research and Innovation in the Health System (PRIHS)

Our partnership with Alberta Health Services supports networks of health researchers and clinical practitioners that can identify sustainable solutions to improve overall quality of care and value for money in the health system. Prior to 2015 awards were for up to a maximum of $250,000 per year, for up to 3 years. In 2015, no maximum award amount was set.

Industry Partnered Translational Fund

Our industry partnerships support research and innovation in shared priority areas that show a strong likelihood of technology transfer and commercialization into products, tools, therapies and services to address needs in the health system.

Alberta/Novartis Translational Research Fund: a partnership with Novartis Pharmaceuticals Canada Inc. (Novartis) and the Government of Alberta to catalyze the development of innovations in health that support the interests and priorities of Alberta, Novartis and their partners. Up to a maximum of $100,000 per year, for up to 3 years.

Alberta/Pfizer Translational Research Fund: a partnership with Pfizer Canada Inc., Western Economic Diversification (WD) Canada, and Alberta’s Innovation and Advanced Education ministry to support research and innovations in shared priority areas that show promise of commercial development into new products and services for improving health and addressing needs in the health system. Up to $200,000 for up to a maximum of 18 months.

Translational Health Chairs Program

A partnership with Alberta’s Comprehensive Academic and Research Institutions to recruit translational health leadership in priority areas to improve health and the health system. From $250,000 up to $600,000 per year for 7 years.

Knowledge Exchange Grants

We support the uptake, adoption and use of evidence created in Alberta and abroad to improve health and the healthcare system.

Community Engagement and Conference Grant: Supports a broad spectrum of activities that promote collaboration and networking in the area of health research and innovation between community groups, individuals, research groups, academic institutions, and organizations in Alberta and beyond. Up to $10,000.

Knowledge-to-Action Grant: Supports the uptake of research evidence into health policy, practice and commercial development of products; and helps to build the growing body of evidence for the most effective ways to approach knowledge translation. Up to a $25,000 for up to 1 year.

Visiting Professorships: Supports visits to Alberta by internationally recognized experts with distinguished careers who will contribute to trainee education, support research progression, assist planning or launching of new research, and/or the evaluation of AIHS funded programs. Funding amount determined at time of request. No set deadline. Due three months prior to proposed visit.


Visiting Scientists: Supports visits to Alberta by leading health scientists or visits of Alberta scientists to other major research centres to enable our health researchers to learn new approaches, knowledge, technology expertise and/or concepts to enhance the provincial health research and innovation environment. Funding amount determined at time of request. Term from one month to 12 months.

Legacy Funding Opportunities

Now closed to entry. Provided multi-year funding for highly qualified researchers in undefined, broad research areas. Funding opportunities included: Interdisciplinary Teams Grants (ITGs), Alberta Cancer Grants, and Independent Investigator Awards.

TRAINEE SUPPORT

Graduate Studentships & Postgraduate Fellowships

We provide opportunities that support trainees in gaining broad experience in the health research environment to help them succeed in launching careers in academia, industry, government or elsewhere.

Graduate Studentships: Provides funding for individuals enrolled in a thesis-based Master’s or PhD program in a health-related research area at an Alberta university. Provides $30,000 stipend and a research and career development allowance of $2,000 per year for up to 4 years (maximum of 2 years support towards a Master’s degree). PLUS option provides up to one year of additional support so that trainees can work in a non-research or different research environment.

Postgraduate Fellowships: Provides funding for individuals with a PhD and/or professional health degree (without clinical accreditation in Canada) who have a post-doctoral appointment at an Alberta university in a health professional or health related program. Provides $50,000 per year, and a research and career development allowance of $5,000 per year for up to 3 years.

AIHS Cy Frank Fellowship: Impact Assessment: Provides funding for individuals with a PhD to pursue training in impact assessment in the field of health research and innovation at AIHS. $70,000 per year for up to 3 years.

Clinician Researcher Training

We are helping to meet the need for clinician scientists: individuals with medical training and research experience who develop research questions encountered in practice and translate their findings into care. Our funding enables the training of clinician scientists who split their time between clinical training or practice and research.

MD-PhD Studentship: Provides support for individuals pursuing combined MD-PhD degrees at an Alberta university. Provides $30,000 per year, and a research and career development allowance of $2,000 per year for up to 6 years.

Clinician Fellowship: Provides support for individuals who have clinical credentials in Canada to pursue graduate and postgraduate research in a health professional or health-related program in Alberta. Provides $70,000 per year, and a research and career development allowance of $5,000 per year for up to 3 years.


Undergraduate & High School

Our funding provides hands-on learning experiences in health research during the summer months for young people considering formal research training and/or a career in the health research.

HYRS: Heritage Youth Researcher Summer Program: Provides an opportunity for exceptional Grade 11 students to gain a direct experience of health research at an Alberta university for six weeks in the summer. $2,000 (approximate figure) for 6 weeks. Stipend only. NOTE: Program moving from AIHS August 31, 2015

Summer Studentships: Provides opportunities for students with exceptional academic standing and who are registered in an undergraduate program to participate in health research in Alberta during the summer. $1,400 per month; stipend only; minimum of 2 months to a maximum of 4 months, during the period of May to August.

Media Fellowships

We work with partners to provide internships in media settings that give students the opportunity to learn and apply health science communication skills. Stipend provided is in line with interns with CBC Radio.

AIHS/Mitacs Health Pilot Partnerships

We work with partners to provide internships that give researchers-in-training community-based experiences that enable them to apply their knowledge to real-world health-related research challenges. $15,000 for 4 months (10,000 for intern, $5,000 for project-related expenses); double internships possible.

Legacy Training Awards

Now closed. Alberta Innovates - Health Solutions (AIHS) introduced new programs for Training and Early Career Development in 2012. The former programs were awarded prior to July 1, 2012 and governed under the previous guidelines.


APPENDIX B: CURRENTLY FUNDED PROJECTS & PEOPLE(as of May 1, 2015)

CRIO PROJECTS

Treatment of Cholesterol-dependent Pulmonary Surfactant Dysfunction

Matthias Amrein, University of CalgaryBrent W. Winston, University of Calgary

Autologous Adult Dermal Stem Cell Transplantation to Improve Function of Split Thickness Skin Grafts

Jeffrey A. Biernaskie, University of CalgaryVincent Gabriel, University of Calgary

Towards Personalized Medicine: Novel Approaches to Prognosis and Therapy of Genetically Determined Arrhythmias

Brenda Gerull, University of CalgaryHenry J. Duff, University of CalgarySui R. (Wayne) Chen, University of Calgary A Sensorimotor Contingency-based Musical Walking Program to Promote Healthy Living and Functional Recovery for People Living with Parkinsons Disease

Bin Hu, University of Calgary The Alberta Perinatal Stroke Project

C. Adam Kirton, University of CalgaryJerome Y. Yager, University of AlbertaJohn Andersen, University of Alberta Deep Brain Stimulation for Treatment Resistant Depressive Disorders

Zelma H. T. Kiss, University of Calgary Rajamannar Ramasubbu, University of Calgary

Invariant NKT Cells as the Link between Brain Injury and Susceptibility to Infections

Paul Kubes, University of Calgary

Evaluating the Impact of Alberta Health System Changes on Outcomes in General Internal Medicine

Finlay A. McAlister, University of AlbertaAnn Colbourne, Alberta Health ServicesStafford Dean, Alberta Health Services Bioprocess Production of Skin Derived Precursor (SKP) Schwann Cells as Autologous Cell Therapy for Nerve and Spinal Cord Repair

Rajiv Midha, University of CalgaryMichael S. Kallos, University of Calgary The Human Explanted Heart Program (HELP) at the Mazankowski Alberta Heart Institute: A Translational Bridge for Cardiovascular Medicine

Gavin Y. Oudit, University of Alberta A Mechanistic Investigation of Behavioral Co-morbidity in Chronic Inflammatory Disorders

Quentin J. Pittman, University of CalgaryBradley J. Kerr, University of AlbertaKeith A. Sharkey, University of Calgary Neurosteroids as Biomarkers and Therapies for Multiple Sclerosis (MS)

Christopher N. Power, University of AlbertaGlen B. Baker, University of AlbertaGregg Blevins, University of Alberta Modulation of Stem Cell Pluripotency and Differentiation via Mechanotransduction in Bioreactors

Derrick E. Rancourt, University of Calgary Production of Adult Synovial Stem Cell Based Tissue Engineered Constructs to Clinically Treat Cartilage Defects

Arindom Sen, University of Calgary David A. Hart, University of CalgaryNeil A. Duncan, University of Calgary


Implementation and Validation of the “5As Framework of Obesity Management” in Primary Care

Arya M. Sharma, University of AlbertaDenise Campbell-Scherer, University of AlbertaSheri Fielding, Primary Care Network Sustaining Transfers through Affordable Research Translation (START): Knowledge Translation Interventions to Support the Uptake of Innovations in Continuing Care Settings

Susan E. Slaughter, University of AlbertaAllyson Jones, University of AlbertaCarole A. Estabrooks, University of AlbertaAdrian Wagg, University of AlbertaMisha Eliasziw, Tufts University

How does Management of Chronic Obstructive Pulmonary Disease Hospitalizations affect Patient-centred Health Outcomes and Cardiovascular Risk?

Michael K. Stickland, University of AlbertaRichard Leigh, University of CalgaryMohit Bhutani, University of Alberta The Development of Highly Efficient and Specific Multi-modal Contrast Agents for Breast Cancer Diagnosis

* Boguslaw Tomanek, University of CalgaryB. Gino Fallone, University of Alberta Lactoferrin, Lysozyme and Lipocalins; from Natural Anti-infective Eye-drops to Treating Sepsis?

Hans J. Vogel, University of Calgary

A New Molecular Platform for Studying Parkinson’s Disease: Molecular Mechanisms and Therapeutic Targets

Michael Woodside, University of AlbertaNils O. Petersen, University of Alberta Intensive Motor Training After Perinatal Stroke to Enhance Walking

Jaynie F. Yang, University of Alberta Monica A. Gorassini, University of Alberta

* ACPLF

CRIO PROGRAMS

Promoting Appropriate Maternal Body Weight in Pregnancy and Postpartum through Healthy Dietary Intake

Rhonda C. Bell, University of AlbertaLinda J. McCargar, University of AlbertaPaula J. Robson, Alberta Health Services Alberta Program in Youth Sport and Recreational Injury Prevention

Carolyn A. Emery, University of CalgaryBrent E. Hagel, University of Calgary Addressing Community Concerns about Health Risks from H.pylori Infection

Karen J. Goodman, University of Alberta Advance Care Planning and Goals of Care Alberta: A Population Based Knowledge Translation Intervention Study

Neil A. Hagen, University of CalgaryKonrad P. Fassbender, University of AlbertaJessica E. Simon, Alberta Health Services Pharmacokinetic and Radiation Dosimetry Evaluations of IAZA and its Translation in Molecular Theranostic Management of Solid Tumors

Michael Weinfeld, University of AlbertaPiyush Kumar, University of AlbertaNaresh Jha, University of AlbertaJohn R. Mercer, University of Alberta Alexander (Sandy) McEwan, University of AlbertaHans-Sonke F. Jans, University of Alberta

An Interdisciplinary Program to Develop Therapeutic Interventions for Peroxisome Disorders

Richard A. Rachubinski, University of AlbertaAndrew J. Simmonds, University of AlbertaNancy Braverman, McGill University


CRIO TEAMS COHORT 1M A R C H 2 013

Development of a Clinical Linac-MR System for Image-guided Radiation Therapy

B. Gino Fallone, University of Alberta W21C: Interdisciplinary Research and Innovation for Health System Quality and Safety

William A. Ghali, University of CalgaryHenry T. Stelfox, University of CalgaryJohn M. Conly, Foothills Hospital

Development of a Vaccine Against the Hepatitis C Virus (HCV) and Demonstration of Efficacy in Intravenous Drug Users

Michael Houghton, University of AlbertaD. Lorne Tyrrell, University of Alberta Alberta Ocular Gene Therapy Team

Ian M. MacDonald, University of AlbertaTania Bubela, University of Alberta Leading Clinical Trials in Islet and Stem Cell Transplantation, Restoration of Self-tolerance and Beta Cell Regeneration - Solving the Supply and Survival Problem in Type 1 Diabetes

A. M. James Shapiro, University of AlbertaPeter E. Light, University of AlbertaLori West, University of Alberta

Metabolomic Devices for Companion Diagnostics and Personalized Medicine

David S. Wishart, University of Alberta

CRIO TEAMS COHORT 2A P R I L 2 014

Alberta Provincial Pediatric EnTeric Infection TEam (APPETITE): Epidemiology, Emerging Organisms, and Economics

Stephen Freedman, University of CalgaryBonita E. Lee, University of Alberta Marie Louie, University of Calgary Xiaoli L. Pang, University of Alberta

Improving the Efficient and Equitable Care of Patients with Chronic Medical Conditions: Interdisciplinary Chronic Disease Collaboration (ICDC)

Brenda Hemmelgarn, University of Calgary Braden J. Manns, University of Calgary Marcello A. Tonelli, University of Alberta Quality Improvement - Clinical Research (QuICR): Alberta Stroke Team

Michael D. Hill, University of Calgary Ashfaq Shuaib, University of Alberta Andrew M. Demchuk, University of Calgary Thomas Jeerakathil, University of Alberta

Return on Investments in Innovative Interventions that Promote Healthy Eating and Active Living among Children Veugelers, Paul J. University of Alberta Ohinmaa, Arto E. University of Alberta Medicines for Remyelination in Multiple Sclerosis: The Next Frontier

Voon Wee Yong, University of Calgary Luanne M. Metz, University of Calgary


CANCER PREVENTION RESEARCH OPPORTUNITY (CPRO) - 1

Novel Biomarkers and Therapeutics for Intestinal Inflammation and Colorectal Cancer

Shairaz Baksh, University of Alberta Levinus A. Dieleman, University of Alberta Carlos A. Velazquez, University of Alberta Marius Sudol, Geisinger Health System

PIK3CA Mutation and Associated Pathway Activation Status and Survival in Patients with Cervical Cancer: Quantifying the Risk and Testing the Solution

Corinne Doll, University of Calgary Susan P. Lees-Miller, University of Calgary Martin Koebel, University of Calgary Prafull Ghatage, University of Calgary

Non-invasive Staging of Prostate Cancer: Translating Biomarkers to Clinical Practice

John D. Lewis, University of Alberta Ronald B. Moore, University of Alberta Immunotherapy for Cancer - Repurposing Targeted Therapeutics with Oncolytic Viruses

Don Morris, University of CalgaryPaul P. Beaudry, University of Calgary Doug Mahoney, University of Calgary Improving the Prevention, Diagnosis, and Treatment of Post-transplant Lymphoproliferative Disorders after Solid Organ Transplantation using Peripheral Blood and Tissue Biomarkers

Jutta K. Preiksaitis, University of Alberta Raymond K. Lai, University of Alberta Anthea C. Peters, University of Alberta Upton D. Allen, University of Toronto

Development of New Imaging Agents and Therapeutic Platforms for Improving Clinical Outcomes for Brain Tumour Patients

Stephen M. Robbins, University of Calgary Donna L. Senger, University of Calgary Warren Chan, University of Toronto Sheila Singh, McMaster University

Interactions of Targeted Anticancer Drugs with Nucleoside Transporters and the Roles of Nucleoside Binding Proteins in Targeted Anticancer Drug Toxicities

Michael B. Sawyer, University of AlbertaJames D. Young,University of Alberta Attitudes Towards Cancer in Arctic Communities & Examining Uptake of Screening Services: The ACCESS Project

Sangita Sharma, University of Alberta Carolyn C. Gotay, University of British Columbia Fariba Kolahdooz, University of Alberta Mohammadreza Pakseresht, University of Alberta

Toward Improved Outcomes of Antithymocyte Globulin-conditioned Hematopoietic Cell Transplantation

Jan Storek, University of CalgaryDon Morris, University of CalgaryFaisal M. Khan, University of Calgary A Semi-automated Surgeon’s Assistant for Prostate Brachytherapy

Mahdi Tavakoli, University of Alberta Ronald S. Sloboda, University of Alberta Nawaid H. Usmani, University of Alberta Specialty SONAR (Study Of Natural health products Adverse Reactions) Focus on Cancer Subjects

Sunita Vohra, University of AlbertaSunil Desai, University of AlbertaPeter Venner, University of Alberta

Targeting the STAT3 Signalling Pathway in Glioblastoma

Samuel Weiss, University of CalgaryH. Artee Luchman, University of Calgary Gregory Cairncross, University of Calgary Patrick T. Gunning, University of Toronto


CANCER PREVENTION RESEARCH OPPORTUNITY (CPRO) - 2

Innovative Diagnostics to Improve the Management of Urothelial Carcinoma

Matthew Eric Hyndman, University of CalgaryDon Morris, University of Calgary Preclinical Theranostic Evaluations of Solid Tumors using FAZA and its Prodrugs (TEST-F): A Hypoxia-selective ‘Bench to Bedside’ Innovation for Cancer Management

Michael Weinfeld, University of Alberta Hans-Sonke F. Jans, University of Alberta Sandy McEwan, University of Alberta David Murray, University of Alberta Piyush Kumar, University of Alberta

Novel Nanoparticulate STAT3 Inhibitors for Treating Multiple Myeloma

Raymond K. Lai, University of Alberta Quincy S. Chu, University of Alberta Afsaneh Lavasanifar, University of Alberta Christopher P. Venner, University of Alberta Developing and Testing a New Treatment for Oral Squamous Cell Carcinoma

Karl T. Riabowol, University of Calgary Joseph C. Dort, University of CalgaryDon Morris, University of Calgary Activating Microglia and Macrophages to Suppress Brain Tumor-initiating Cells

Voon Wee Yong, University of Calgary Jeffery F. Dunn, University of CalgaryJohn J. Kelly, University of Calgary

CRIO POPULATION RESILIENCY - PROGRAM

Alberta Resilient Communities Research Project: Engaging Children and Youth in Community Resilience Post-flood in Southern Alberta

Julie Drolet, University of Calgary Robin S. Cox, Royal Roads College Caroline McDonald-Harker, Mount Royal College

CRIO POPULATION RESILIENCY - TEAM

Prediction and Understanding of Resilience in Alberta Families: Longitudinal Study of Disaster Responses (PURLS)

Dawn Kingston, University of Alberta Anrew Greenshaw, University of Alberta Sheila McDonald, Alberta Health Services Suzanne Tough, University of Calgary

INTERDISCIPLINARY TEAM GRANT

AHFMR Interdisciplinary Team Grant on Understanding and Treating Diastolic Heart Failure: Novel Mechanisms, Diagnostics and Potential Therapeutics

Jason Dyck, University of AlbertaTodd Anderson, University of Calgary


STRATEGIC CLINICAL NETWORK: CRITICAL CARE Identifying and Evaluating Intensive Care Unit Capacity Strain in Alberta

Sean Bagshaw, University of Alberta Henry T. Stelfox, University of Calgary STRATEGIC CLINICAL NETWORK: CARDIOVASCULAR & STROKE

Efficient / Effective Delivery & Follow-up of Cardiovascular Implantable Electrical Devices in Alberta: Performance Evaluation & Rhythm Follow-up Optimization with Remote Monitoring (PERFORM) Collaborative Project

Derek V. Exner, University of Calgary Sandeep Aggarwal, University of CalgaryBrian Buck, University of Alberta Andrew M. Demchuk, University of CalgarySajad Gulamhusein, University of Alberta Colleen M. Norris, University of Alberta Roopinder K. Sandhu, University of Alberta Stephen B. Wilton, University of Calgary

STRATEGIC CLINICAL NETWORK: DIABETES, OBESITY & NUTRITION

Care and Rehabilitation for Patients with Severe Obesity in Alberta’s Tertiary Care Settings

Mary Forhan, University of Alberta Jeffrey A. Johnson, University of AlbertaArya M. Sharma, University of Alberta STRATEGIC CLINICAL NETWORK: SURGERY Enhancing Patients’ Recovery After Surgery (ERAS): Strategy to Transform Care and Maximize Value

Leah M. Gramlich, Alberta Health Services Gregg S. Nelson, University of Calgary STRATEGIC CLINICAL NETWORK: SENIORS’ HEALTH

Optimizing Seniors Surgical Care - The Elder Friendly Surgical Unit

Rachel G. Khadaroo, University of AlbertaFiona Clement, University of CalgaryJayna Holroyd-Leduc, Alberta Health ServicesRaj Padwal, University of Alberta Adrian Wagg, University of Alberta

STRATEGIC CLINICAL NETWORK: EMERGENCY

Improving the Stewardship of Diagnostic Imaging Resources in Alberta Emergency Departments

Eddy S. Lang, University of CalgaryJames Andruchow, University of Calgary Michael J. Bullard, University of Alberta Derek J. Emery, University of AlbertaBrian Holroyd, University of Alberta Andrew D. McRae, University of CalgaryBrian H. Rowe, University of Alberta Robert J. Sevick, University of Calgary

STRATEGIC CLINICAL NETWORK: BONE & JOINT HEALTH Optimizing Centralized Intake to Improve Arthritis Care for Albertans

Deborah A. Marshall, University of CalgaryLinda Woodhouse, University of Alberta STRATEGIC CLINICAL NETWORK: CANCER Rectal Cancer Care Clinical Pathway

Todd P. McMullen, Alberta Health ServicesDon Buie, University of CalgaryNeil A. Hagen, University of Calgary STRATEGIC CLINICAL NETWORK: CRITICAL NETWORK Reassessing Practices in the Daily Care of Critically Ill Patients: Building Capacity and Methodology to Identify & Close Evidence-care Gaps

Henry T. Stelfox, University of CalgarySean Bagshaw, University of Alberta STRATEGIC CLINICAL NETWORK: BONE & JOINT HEALTH

SpineAccess Alberta: An Innovative Health Service Delivery and Spine Management Model

Linda Woodhouse, University of Alberta Gregory N. Kawchuk, University of AlbertaLeah Phillips, Alberta Health Services

PARTNERSHIP FOR RESEARCH AND INNOVATION IN THE HEALTH SYSTEM (PRIHS)


ALBERTA/PFIZER TRANSLATIONAL RESEARCH FUND 1

MR Quantitative Iron Imaging in Alzheimer’s Disease and Dementia

Richard Frayne, University of CalgaryEric E. Smith Predictive Biomarkers of Taxane Response

Ing Swie Goping, University of Alberta Judith C. Hugh John R. Mackey Todd P. McMullen

Development and Validation for a Novel Rescue Therapy for Severe Asthma

Francis H. Green, University of Calgary Richard Leigh Development of Disease Modifying Therapies for Huntington’s Disease

Simonetta Sipione, University of Alberta

ALBERTA/PFIZER TRANSLATIONAL RESEARCH FUND 2

Novel Multifunctional Small Molecules for the Treatment of Atrial Fibrillation

Jason Dyck, University of Alberta Peter Light, University of Alberta Managing Cardiovascular Contractile Abnormalities with a Novel Inhibitor of Zipper-interacting Protein Kinase

Justin MacDonald, University of Calgary Timothy Haystead, Duke University Bijoy Menon, University of Calgary

A Monoclonal Antibody to Restore Radioiodine Sensitivity and Decrease Tumor Burden in Metastatic Papillary Thyroid Carcinoma

Todd McMullen, University of Alberta John Mackey, University of Alberta

Targeting PI3 Kinase Isoforms to Inhibit Tumor Neovascularization

Allan Murray, University of Alberta Ronald Moore, University of Alberta N-acetylglucosamine Analogs that Promote Remyelination and Reduce Detrimental Inflammation: Novel Therapeutics for Multiple Benefits in Multiple Sclerosis

Voon Wee Yong, University of Calgary Chang-Chun Ling, University of Calgary Regulation of T-type Calcium Channel Expression - A Novel Strategy for the Treatment of Pain

Gerald Zamponi, University of Calgary


KNOWLEDGE TO ACTION

Improving Knowledge Regarding Pregnancy and Inflammatory Bowel Disease

Richard N. Fedorak, University of Alberta Vivian W. Huang, University of Alberta Outcomes in Child Health: A Qualitative Study of Social Media for Stakeholder Engagement

Lisa A. Hartling, University of Alberta Ricardo M. Fernandes, University of Lisbon Michele Hamm, University of AlbertaAmy Plint, University of OttawaBrian H. Rowe, University of Alberta Shannon D. Scott, University of Alberta

Improving Care Adults with Parkinson’s Disease and Dementia Complicated by Comorbid Depression and Anxiety

Jayna Holroyd-Leduc, University of Calgary Zahra S. Goodarzi, University of Calgary

Utility of a Clinical Diagnostic Algorithm to Reduce CT Imaging for ED Patients with Suspected Renal Colic

Grant Innes, University of Calgary James Andruchow, University of Calgary Building Capacity for Evidence-informed Decision-making Around the Introduction of New Technologies: Rolling Out the “Evidence Decision Support Program” to New Strategic Clinical Network

Paule M. Poulin, University of CalgaryLuke Rudmik, University of Calgary Trevor Schuler, University of Alberta Metabolomics of Airway Diseases: Improving Management in the Emergency Department

Brian Rowe, University of Alberta Darryl Adamko, University of Saskatchewan Retiring Minds Want to Know: Understanding Seniors Knowledge About Research Practices and its Affect on Their Attitude Towards Participation

Rachel Syme, University of Calgary Suzanne Vorvis, Alberta Health Services

A Knowledge Translation Pilot Intervention in Community Pharmacies using the PARiHS Framework

Ross T. Tsuyuki, University of Alberta Increasing Usability of Administrative Healthcare Data Through a Web-based Tool for Systematic Exploration of Medical Coding Ontologies

Samuel Wiebe, University of Calgary

TRANSLATIONAL HEALTH CHAIRS PROGRAM

Nicholas AshboltUniversity of Alberta, School of Public Health

Cheryl L. Currie University of Lethbridge, Health Sciences

Lee A. Green University of Alberta, Medicine & Dentistry

Ian Lewis University of Calgary, Science

Lynne-Marie Postovit University of Alberta, Medicine & Dentistry

VISITING SCIENTIST HOST:

Vivian K. Mushahwar University of Alberta

CANDIDATE:

Eberhard E. Fetz Physiology & Biophysics, University of Washington Seattle, Washington


TRAINEE SUPPORT

Graduate Studentships

Liane Babes, University of Calgary ACPLF - Graduate StudentshipDenise E. Bustard, University of Calgary ACPLF - Graduate StudentshipJuliana S. Capitanio, University of Alberta ACPLF - Graduate StudentshipDouglas E. Friesen, University of Alberta ACPLF - Graduate StudentshipShyam Madhusudan Garg, University of Alberta ACPLF - Graduate StudentshipSeyyed M. Kazemi-Bajestani, University of Alberta ACPLF - Graduate StudentshipBrent A. McLean, University of Alberta ACPLF - Graduate StudentshipRebecca J. Mercier, University of Alberta ACPLF - Graduate StudentshipXiaobin Mo, University of Alberta ACPLF - Graduate StudentshipHali A. Morrison, University of Alberta ACPLF - Graduate StudentshipManoj B. Parmar, University of Alberta ACPLF - Graduate StudentshipKaitlyn M. Towle, University of Alberta ACPLF - Graduate StudentshipJuliana Valencia Serna, University of Alberta ACPLF - Graduate StudentshipGanesh Venkatraman, University of Alberta ACPLF - Graduate StudentshipAhmed S. Abdelfattah, University of Alberta Graduate StudentshipChristina A. Ahlstrom, University of Calgary Graduate StudentshipRoger A. Ashmus, University of Alberta Graduate StudentshipJillian L. S. Avis, University of Alberta Graduate StudentshipBriana D. Cassetta, University of Calgary Graduate StudentshipPatrick Ciechanski, University of Calgary Graduate Studentship

Anne-Francoise J. P. Close, University of Alberta Graduate StudentshipStephen A. Cochrane, University of Alberta Graduate StudentshipSubhash K. Das, University of Alberta Graduate StudentshipChelsea L. Davidson, University of Alberta Graduate StudentshipBradley D. Day, University of Calgary Graduate StudentshipSutherland T. A. Dube, University of Lethbridge Graduate StudentshipShane E.A. Eaton, University of Calgary Graduate StudentshipKristofor K. Ellestad, University of Alberta Graduate StudentshipAhmed A. El-Sherbeni, University of Alberta Graduate StudentshipNatasha Fillmore, University of Alberta Graduate StudentshipDominic P. Golec, University of Alberta Graduate StudentshipAhmed M. Hashad, University of Calgary Graduate StudentshipAmmar Hassanzadeh Keshteli, University of Alberta Graduate StudentshipRoopa Hebbandi Nanjundappa, University of Calgary Graduate StudentshipBrett T. Himmler, University of Lethbridge Graduate StudentshipVeronika Kiryanova, University of Calgary Graduate StudentshipChristen M. Klinger, University of Alberta Graduate StudentshipDylan R.J. Kobsar, University of Calgary Graduate StudentshipRanjan Kumar, University of Calgary Graduate StudentshipPatricia Leighton, University of Alberta Graduate Studentship


Irene Liu, University of Calgary Graduate StudentshipYingjie Liu, University of Calgary Graduate StudentshipKelsey D. Lucyk, University of Calgary Graduate StudentshipDanielle C. Lynch, University of Calgary Graduate StudentshipDun Mao, University of Lethbridge Graduate StudentshipShaun M.K. McKinnie, University of Alberta Graduate StudentshipSheldon D. Michaelson, University of Alberta Graduate StudentshipLuis C. Morales, University of Alberta Graduate StudentshipMichael J. Mousseau, University of Calgary Graduate StudentshipMyung-Chul (Sam) Noh, University of Alberta Graduate StudentshipVan A. Ortega, University of Alberta Graduate StudentshipMarc A. Parsons, University of Alberta Graduate StudentshipJoshua Pemberton, University of Alberta Graduate StudentshipJennifer L. Prentice, University of Calgary Graduate StudentshipLeanne Quigley, University of Calgary Graduate StudentshipJoshua A. Rash, University of Calgary Graduate StudentshipRuksana S. Rashid, University of Calgary Graduate StudentshipJames A. Rogers, University of Calgary Graduate StudentshipCodie R. Rouleau, University of Calgary Graduate StudentshipKhara M. Sauro, University of Calgary Graduate StudentshipSabine I. Schmelz, University of Alberta Graduate StudentshipJonathon S. Schofield, University of Alberta Graduate Studentship

Brittney N.V. Scott, University of Calgary Graduate StudentshipSimon A. Sharples, University of Calgary Graduate StudentshipMichael J. Spilka, University of Calgary Graduate StudentshipErin L. Stephenson, University of Calgary Graduate StudentshipAlexander Y.W. Suen, University of Alberta Graduate StudentshipHo-Yan Sun, University of Alberta Graduate StudentshipJennifer L. Swan, University of Calgary Graduate StudentshipCharmaine L. Thomas, University of Calgary Graduate StudentshipAmirali Toossi, University of Alberta Graduate StudentshipScott G. Travis, University of Alberta Graduate StudentshipSarah C. Treit, University of Alberta Graduate StudentshipDaniel Unterweger, University of Alberta Graduate StudentshipHaris M. Vaid, University of Calgary Graduate StudentshipIsabelle A. Vallerand, University of Calgary Graduate StudentshipMarie Betsy Varughese, University of Alberta Graduate StudentshipRobin L. Walker, University of Calgary Graduate StudentshipQian Wang, University of Alberta Graduate StudentshipMichele B. Wellsby, University of Calgary Graduate StudentshipLindsey M. Westover, University of Alberta Graduate StudentshipThomas R. Whitesell, University of Calgary Graduate StudentshipJames P. Wick, University of Calgary Graduate StudentshipGrey A. Wilkinson, University of Calgary Graduate Studentship


Dong Yan, University of Calgary Graduate StudentshipElaine E.O. Hyshka, University of Alberta Health Research - Full-Time StudentshipJillian A. Johnson, University of Calgary Health Research - Full-Time StudentshipJiaying Liu, University of Alberta Health Research - Full-Time StudentshipKristin R. Newman, University of Calgary Health Research - Full-Time StudentshipLinette D. Savage, University of Calgary Health Research - Full-Time StudentshipMarc R. Bomhof, University of Calgary Studentship - Full-TimeSean C. Booth, University of Calgary Studentship - Full-TimePhillip L.W. Colmers, University of Calgary Studentship - Full-TimeMichael M. DuVall, University of Calgary Studentship - Full-TimeCara E. Ellis, University of Alberta Studentship - Full-TimeJustin G. Fedor, University of Alberta Studentship - Full-TimeMaria R. Fernando, University of Calgary Studentship - Full-TimeTrisha M. Finlay, University of Calgary Studentship - Full-TimeNichole M. Flynn, University of Calgary Studentship - Full-TimeErin L. Garside, University of Alberta Studentship - Full-TimeAngela M. Getz, University of Calgary Studentship - Full-TimeCatherine Hajmrle, University of Alberta Studentship - Full-TimeEmily K. Herman, University of Alberta Studentship - Full-TimeCurtis D. Hodge, University of Alberta Studentship - Full-TimeKathrin Koblinger, University of Calgary Studentship - Full-TimeGabriella Leung, University of Calgary Studentship - Full-Time

Erin-Mai F. Lim, University of Calgary Studentship - Full-TimeLeiah M. Luoma, University of Alberta Studentship - Full-TimeJames Mackay, University of Alberta Studentship - Full-TimeChelsea E. Matisz, University of Calgary Studentship - Full-TimeLeanne Mortimer, University of Calgary Studentship - Full-TimeHeather A.S. Paul, University of Calgary Studentship - Full-TimeSandra E. Pineda Sanabria, University of Alberta Studentship - Full-TimeLaura M. Reyes, University of Alberta Studentship - Full-TimeKathleen A. Scullion, University of Calgary Studentship - Full-TimeSara R. Turner, University of Calgary Studentship - Full-TimeNicholas L. Weilinger, University of Calgary Studentship - Full-TimeSteven D. Willows, University of Alberta Studentship - Full-TimeXiaowei Zhong, University of Calgary Studentship - Full-TimeCameron Clark, University of Calgary Studentship - Mental Health ResearchJennifer D. Ference, University of Calgary Studentship - Mental Health ResearchPerla A. Cota-Elizondo, Resverlogix Graduate Studentship - PLUSLauren E. Killip, Focal Healthcare Inc. Graduate Studentship - PLUS


MD-PhD Studentship

Matthew G.K. Benesch, University of Alberta ACPLF-Clinician Researcher MD-PhD StudentshipLauren C. Capozzi, University of Calgary ACPLF-Clinician Researcher MD-PhD StudentshipErin S. Degelman, University of Calgary ACPLF-Clinician Researcher MD-PhD StudentshipKristen I. Barton, University of Calgary Clinician Researcher - MD-PhD StudentshipCraig A. Beers, University of Calgary Clinician Researcher - MD-PhD StudentshipBrandon M. Hisey, University of Calgary Clinician Researcher - MD-PhD StudentshipRyan J. Leigh, University of Calgary Clinician Researcher - MD-PhD StudentshipRyan T. Lewinson, University of Calgary Clinician Researcher - MD-PhD StudentshipTaryn E. Ludwig, University of Calgary Clinician Researcher - MD-PhD StudentshipNabeela Nathoo, University of Calgary Clinician Researcher - MD-PhD StudentshipLaura A. Palmer, University of Calgary Clinician Researcher - MD-PhD StudentshipWaleed M. Rahmani, University of Calgary Clinician Researcher - MD-PhD StudentshipAmrita Roy, University of Calgary Clinician Researcher - MD-PhD StudentshipJames A. Cotton, University of Calgary Studentship - MD/PhDZaheed Damani, University of Calgary Studentship - MD/PhDAlexandra D. Frolkis, University of Calgary Studentship - MD/PhDMichael B. Keough, University of Calgary Studentship - MD/PhDChristina S. Thornton, University of Calgary Studentship - MD/PhD

Clinician Fellows

Mohammad Ali, University of Alberta ACPLF - Clinician FellowshipGabriela Constantinescu, University of Alberta ACPLF - Clinician FellowshipAmy Hobbs, University of Calgary ACPLF - Clinician FellowshipVijay Ramaswamy, The Hospital for Sick Children ACPLF - Fellowship - ClinicalKevin R. Boldt, University of Calgary Clinician Researcher - Clinician FellowshipDavid J.T. Campbell, University of Calgary Clinician Researcher - Clinician FellowshipBrea D. Chouinard, University of Alberta Clinician Researcher - Clinician FellowshipCatherine A. Eastwood, University of Calgary Clinician Researcher - Clinician FellowshipMeghan J. Elliott, University of Toronto Clinician Researcher - Clinician FellowshipSonja E. Findlater, University of Calgary Clinician Researcher - Clinician FellowshipBoris L. Gala Lopez, University of Alberta Clinician Researcher - Clinician FellowshipTamara H. Germani, University of Alberta Clinician Researcher - Clinician FellowshipLaura Catherine Gioia, University of Alberta Clinician Researcher - Clinician FellowshipJoey K. Grochmal, University of Calgary Clinician Researcher - Clinician FellowshipVivian W. Huang, University of Alberta Clinician Researcher - Clinician FellowshipColin B. Josephson, University of Calgary Clinician Researcher - Clinician FellowshipMahesh P. Kate, University of Alberta Clinician Researcher - Clinician FellowshipGraham Z. MacDonald, University of Calgary Clinician Researcher - Clinician FellowshipShannon E. MacDonald, University of Calgary Clinician Researcher - Clinician FellowshipHolly E. Mewhort, University of Calgary Clinician Researcher - Clinician FellowshipKarim Michail, University of Alberta Clinician Researcher - Clinician Fellowship


Kara Murias, University of Calgary Clinician Researcher - Clinician FellowshipDaniel J. Niven, University of Calgary Clinician Researcher - Clinician FellowshipJoseph J. Pagano, University of Alberta Clinician Researcher - Clinician FellowshipAylin Y. Reid, University of California, Los Angeles Clinician Researcher - Clinician FellowshipDerek J. Roberts, University of Calgary Clinician Researcher - Clinician FellowshipHumam Saltaji, University of Alberta Clinician Researcher - Clinician FellowshipRaina Soudy, University of Alberta Clinician Researcher - Clinician FellowshipKaren Tang, University of Calgary Clinician Researcher - Clinician FellowshipStephanie E. Thompson, University of Alberta Clinician Researcher - Clinician FellowshipDaniel Yavin, University of Calgary Clinician Researcher - Clinician FellowshipBeshay N.M. Zordoky, University of Alberta Clinician Researcher - Clinician FellowshipHumberto Jijon, Harvard Medical School Fellowship - Clinical

Postgraduate Fellows

Sambuddha Banerjee, University of Calgary ACPLF - Postgraduate FellowshipDavid J. E. Bond, University of Alberta ACPLF - Postgraduate FellowshipMohamed A. M. El Gendy, University of Alberta ACPLF - Postgraduate FellowshipRuo-Xu Gu, University of Calgary ACPLF - Postgraduate FellowshipShrivani Pirahas, University of Calgary ACPLF - Postgraduate FellowshipShahzada Junaid S. Qazi, University of Calgary ACPLF - Postgraduate FellowshipJudit Voros, University of Alberta ACPLF - Postgraduate FellowshipShereen M. Hamza, University of Alberta Fellowship - Full Time

Dolan Champa Saha, University of Calgary Fellowship - Full TimeLuciana G. Macedo, University of Alberta Health Research - Full-Time FellowshipBasant Abdulrahman, University of Calgary Postgraduate FellowshipMisagh Alipour, University of Alberta Postgraduate FellowshipAnwar Anwar-Mohamed, University of Alberta Postgraduate FellowshipEugene Asahchop, University of Alberta Postgraduate FellowshipHamideh Bayrampour, University of Calgary Postgraduate FellowshipJillian E. Beveridge, University of Calgary Postgraduate FellowshipAndrew V. Caprariello, University of Calgary Postgraduate FellowshipAlison Care, University of Alberta Postgraduate FellowshipMatthew A. Churchward, University of Alberta Postgraduate FellowshipDarren Clark, University of Calgary Postgraduate FellowshipDerek R. Dee, University of Alberta Postgraduate FellowshipJustin F Deniset, University of Calgary Postgraduate FellowshipElizabeth Dogherty, University of Alberta Postgraduate FellowshipLauren L. Drogos, University of Calgary Postgraduate FellowshipJordan D. T. Engbers, University of Calgary Postgraduate FellowshipKeith Fenrich, University of Alberta Postgraduate FellowshipBrandon L. Findlay, University of Alberta Postgraduate FellowshipChristian Foerster, University of Alberta Postgraduate FellowshipShelagh K. Genuis, University of Alberta Postgraduate FellowshipJessica Gifford, University of Alberta Postgraduate Fellowship


Megan Gray, University of Calgary Postgraduate FellowshipMatthias Hoben, University of Alberta Postgraduate FellowshipCharlie Y.M. Hsu, University of Calgary Postgraduate FellowshipMin Jun, University of Calgary Postgraduate FellowshipAnand Krishnan, University of Alberta Postgraduate FellowshipTamia K. Lapointe, University of Calgary Postgraduate FellowshipJoseph A. Lemire, University of Calgary Postgraduate FellowshipAviad Levin, University of Alberta Postgraduate FellowshipDaniel Limonta Velazquez, University of Alberta Postgraduate FellowshipAlexander W. Lohman, University of Calgary Postgraduate FellowshipEmilie Magaud, University of Calgary Postgraduate FellowshipMohsen Maleki Karyak, University of Calgary Postgraduate FellowshipManmeet K. Mamik, University of Alberta Postgraduate FellowshipLeah J. Martin, University of Alberta Postgraduate FellowshipErin L. Mazerolle, University of Calgary Postgraduate FellowshipLindsay Naef, University of Calgary Postgraduate FellowshipVan A. Ngo, University of Calgary Postgraduate FellowshipNirmal Parajuli, University of Alberta Postgraduate FellowshipHeekuk Park, University of Alberta Postgraduate FellowshipVaibhav Patel, University of Alberta Postgraduate FellowshipAngkoon Phinyomark, University of Calgary Postgraduate FellowshipGeoffrey A. Power, University of Calgary Postgraduate Fellowship

Ian M. Robertson, University of Alberta Postgraduate FellowshipDavid G. Rosenegger, University of Calgary Postgraduate FellowshipLori Anne R. Sacrey, University of Alberta Postgraduate FellowshipMohammed Abdullah Sarhan, University of Alberta Postgraduate FellowshipJennifer Semrau, University of Calgary Postgraduate FellowshipSupratik Sen Mojumdar, University of Alberta Postgraduate FellowshipIan Smith, University of Calgary Postgraduate FellowshipFloor Spaans, University of Alberta Postgraduate FellowshipMatthew D. Spencer, University of Calgary Postgraduate FellowshipPatrick L. Stemkowski, University of Calgary Postgraduate FellowshipBo Sun, University of Calgary Postgraduate FellowshipBas Gerardus Johannes Surewaard, University of Calgary Postgraduate FellowshipMireille V. Tittel-Elmer, University of Calgary Postgraduate FellowshipCam Ha Tran, University of Calgary Postgraduate FellowshipChannakeshava S. Umeshappa, University of Calgary Postgraduate FellowshipAnil Kumar Victoria Ansalem, University of Alberta Postgraduate FellowshipXavier Waltz, University of Calgary Postgraduate FellowshipAnil Zechariah, University of Calgary Postgraduate FellowshipFranz J. Zemp, University of Calgary Postgraduate FellowshipFang-Xiong Zhang, University of Calgary Postgraduate FellowshipAgnieszka A. Zurek, University of Calgary Postgraduate Fellowship


Heritage Youth Researcher Summer (HYRS)Program

UNIVERSITY OF ALBERTA

Darya Abdolmaleki, Fort McMurray Westwood Community High School Mentor: Elaine M. Leslie

Kristofer Akkerman, St Albert St Albert Catholic High School Mentor: Ratmir Derda

Mazzen Black, Edmonton Tempo School Mentor: Gina R. Rayat

Neha Goel, Edmonton Lillian Osborne High School Mentor: John D. Lewis

Rachel Goud, Edmonton Jasper Place High School Mentor: Jens Walter

Ben Hallworth, Edmonton Strathcona High School Mentor: Karim Fouad

Tamanna Haque, Fort McMurray Westwood Community High School Mentor: Karen J. Goodman

Ruicen He, Edmonton Old Scona Academic High School Mentor: Carlos A. Fernandez-Patron

Rutuja Kadam, Sherwood Park Salisbury Composite High School Mentor: Andrew J. Simmonds

Claire Kee, Edmonton Archbishop MacDonald Catholic High School Mentor: Michele C. Crites Battie

Brea Kesslar, Edmonton Edmonton Christian High SchoolMentor: Gary D. Lopaschuk

Kylie Kwok, St AlbertPaul Kane High SchoolMentor: Lori J. West

Stephanie Li, EdmontonOld Scona Academic High SchoolMentor: Mary M. Hitt

Christine Lo, Grande Prairie Grande Prairie Composite High SchoolMentor: Sarah C. Hughes

Lucas Mina, EdmontonHoly Trinity Catholic High School Mentor: Thomas Simmen

Colleen Moore, St AlbertPaul Kane High SchoolMentor: Peter E. Light

Tamara Radovic, Edmonton Archbishop MacDonald Catholic High SchoolMentor: Maya Shmulevitz

Aditya Sharma, Grande Prairie Grande Prairie Composite High SchoolMentor: John M. Seubert

Andrea Tack, Edmonton Harry Ainlay High SchoolMentor: Ian MacDonald

Vanessa Vuong, Edmonton McNally High School Mentor: Sandra T. Davidge

Sarah Willette, St AlbertEcole Secondaire Sainte Marguerite d’Youville Mentor: Lynne-Marie Postovit

Jo-Lynn Yen, EdmontonLouis St Laurent Junior/Senior High School Mentor: Christine A. Webber

UNIVERSITY OF CALGARY

Christopher Aitken, Calgary Westmount Charter School Mentor: Stephen B. Wilton

Juan (Sebastian) Alvarez, Calgary Bishop O’Byrne High School Mentor: Campbell P. Rolian

Michelle Chung, Calgary Bishop O’Byrne High School Mentor: Herman Barkema


Jameson A. Dundas, Calgary Rundle College Senior High Mentor: Satish Raj

Shannon Edie, Calgary Queen Elizabeth High School Mentor: Brent Edwards

Katrine Gillett, Canmore Canmore Collegiate High School Mentor: Susan Kutz

Sophie Gobeil, Calgary Bishop Carroll High School Mentor: Sean P. Dukelow

Angie Hu, Calgary St Francis High School Mentor: Kathryn M. King-Shier

Bryan Ma, Calgary Western Canada High School Mentor: Matthew T. James

Jenice Ma, Calgary Western Canada High School Mentor: Walter Herzog

Timothy Marino, Calgary Springbank Community High School Mentor: Derek V. Exner

Mica Pabia, Calgary Bishop McNally High SchoolMentor: Patricia A. Tang

Andrew Panteluk, Red DeerEcole Secondaire Notre Dame Composite High SchoolMentor: Marc J. Poulin

Danna Pham, CalgaryClear Water Academy Mentor: Herman Barkema

Joshua Quan, CalgarySir Winston Churchill High SchoolMentor: Tao Dong

Miranda C. Schmidt, AirdrieBert Church High School Mentor: Karen M. Benzies

Amelia Srajer, CalgaryWest Island CollegeMentor: Frank van der Meer

Natalie Tai, CalgaryWest Island College Mentor: Subrata Ghosh

Natalie Williams, Calgary Central Memorial High School Mentor: Marie E. Fraser

Rebecca Wytsma, Calgary William Aberhart High School Mentor: Aaron A. Goodarzi

Yuwei Xia, CalgaryDr. E.P. Scarlett High SchoolMentor: Careem Faizal

Sophie Zhao, CalgarySir Winston Churchill High SchoolMentor: Naweed I. Syed

UNIVERSITY OF LETHBRIDGE

Eyram A. Asem, Lethbridge Winston Churchill High School Mentor: Robbin L. Gibb

Kai Bailey, Lethbridge Chinook High School Mentor: Bryan E. Kolb

Kate Chua, Lethbridge Catholic Central High School Mentor: Robert J. Sutherland

Grace E. Forster, Lethbridge Lethbridge Collegiate Institute Mentor: Gerlinde A. Metz

Anileen Pageni, Lethbridge Winston Churchill High School Mentor: Ute Kothe

Daniel Rocca, Lethbridge Catholic Central High School Mentor: Hans-Joachim Wieden


Summer Students

UNIVERSITY OF ALBERTA

Raafi Ali, Medicine & Dentistry Supervisor: Vickie E. Baracos

Marya Aman, Medicine & Dentistry Supervisor: David H. Evans

Colin G. Andrews, Medicine & Dentistry Supervisor: Hadi Seikaly

Alexandra Bain, Science Supervisor: Christine M. Szymanski

Ankur Banerjee, Medicine & Dentistry Supervisor: David Westaway

Meredith Bara, Engineering Supervisor: Warren H. Finlay

Diana Bark, Medicine & Dentistry Supervisor: Adrian Wagg

Michael Bell, Science Supervisor: Todd L. Lowary

Grace E. Bellerose, Medicine & Dentistry Supervisor: Jason P. Acker

Michael D. Bildersheim, Medicine & Dentistry Supervisor: Luis M. Schang

Rebecca N. Burchett, Medicine & Dentistry Supervisor: Roseline Godbout

Sylvia Cao, ScienceSupervisor: Ted W. Allison

Ana Catuneanu, Medicine & Dentistry Supervisor: Paige Lacy

Calvin J. Chan, Medicine & Dentistry Supervisor: Paul R. Melancon

Charice S. Chan, Medicine & Dentistry Supervisor: Adrian Wagg

Christopher J. Chan, Medicine & Dentistry Supervisor: David Westaway

Lucila R. Chen, Medicine & Dentistry Supervisor: Christopher McCabe

Patricia A. Chen, Medicine & Dentistry Supervisor: Maya Shmulevitz

Shuo Chen, Medicine & Dentistry Supervisor: Larry Fliegel

Nathan Y. P. Chu, Medicine & Dentistry Supervisor: Joseph Brandwein

Lucas J. Churchill, Medicine & Dentistry Supervisor: Eytan Wine

Nicholas P. Churchill, Science Supervisor: Christine M. Szymanski

Quinn Daviduck, Medicine & Dentistry Supervisor: Rachel G. Khadaroo

Chad Diederichs, Medicine & Dentistry Supervisor: Jacob L. Jaremko

Kristen Dietrich, Science Supervisor: Frederick Colbourne

Victor Do, Medicine & Dentistry Supervisor: Jason R. Dyck

Suraj Sharma Domun, Engineering Supervisor: Hasan Uludag

Abdullah Farooq, Science Supervisor: Jonathan J. Dennis

David Fung, Medicine & Dentistry Supervisor: Sandra T. Davidge

Brandon E. Hauer, Science Supervisor: Clayton T. Dickson

Jesse Hill, Medicine & Dentistry Supervisor: Brian H. Rowe

Yuhao (Danny) Huang, Medicine & Dentistry Supervisor: J. N. Mark Glover

Joshua N. Irwin, Science Supervisor: Mario F. Feldman

Stephania Irwin, Medicine & Dentistry Supervisor: M. Joanne Lemieux

Alexis Katzell, Medicine & Dentistry Supervisor: Gregory D. Funk

Kevin M.W. Khey, Science Supervisor: John C. Vederas

Mary J. Klute, Nursing Supervisor: Shannon D. Scott


Brenda Lam, Medicine & Dentistry Supervisor: Benjamen Montpetit

Brendon Lamarche, Medicine & Dentistry Supervisor: Lori J. West

Andy Le, Science Supervisor: Robert E. Campbell

Kyra J. Lee, Pharmacy and Pharmaceutical Sciences Supervisor: John M. Seubert

Tae Young (Tim) Lee, Medicine & Dentistry Supervisor: M. Joanne Lemieux

Luke R. Leggo, Rehabilitation Medicine Supervisor: Karim Fouad

Dickson H.H. Leung, Medicine & Dentistry Supervisor: Carlos A. Fernandez-Patron

Yibo (Teresa) Li, Medicine & Dentistry Supervisor: Rachel G. Khadaroo

Brandon Lieu, Rehabilitation Medicine Supervisor: Jaynie F. Yang

Isabel Light, Medicine & Dentistry Supervisor: Carmen R. Rasmussen

Ying Ling, Medicine & Dentistry Supervisor: Peter A. Senior

Yuejian (Charlotte) Liu, Medicine & Dentistry Supervisor: Gary A. Eitzen

Kaitlyn Lopushinsky, Medicine & Dentistry Supervisor: Lynne-Marie Postovit

Jenny W. H. Lou, Physical Education & Recreation Supervisor: David F. Collins

Jessica Luc, Medicine & Dentistry Supervisor: Jayan Nagendran

Jingyi (Jenny) Ma, Medicine & Dentistry Supervisor: Karen J. Goodman

Kelly Y. K. Ma, Medicine & Dentistry Supervisor: David M. Olson

Nayef Maarouf, Medicine & Dentistry Supervisor: Richard A. Rachubinski

Tanner Mack, Medicine & Dentistry Supervisor: D. Lorne Tyrrell

Darryl J. Mah, Medicine & Dentistry Supervisor: Jason R. Dyck

Regan S. R. Mah, Medicine & Dentistry Supervisor: Larry Fliegel

Tyler R. McDonald, Science Supervisor: John C. Vederas

Sae Young (Sally) Moon, Medicine & Dentistry Supervisor: Christian Beaulieu

Nerissa Nankissoor, Medicine & Dentistry Supervisor: Joel B. Dacks

Soumil Narayan, Agricultural, Life & Environmental Sciences Supervisor: Vera C. Mazurak

Karl Narvacan, Medicine & Dentistry Supervisor: Christian Beaulieu

Jennifer M. Ng, Medicine & Dentistry Supervisor: Ban Chi-Ho Tsui

Peter Norris, Medicine & Dentistry Supervisor: David H. Evans

Amarjot K. Padda, Medicine & Dentistry Supervisor: Sunita Vohra

Meet Patel, Medicine & Dentistry Supervisor: Casey, Joseph R.

Amanda Paton, Nursing Supervisor: Kingston, Dawn

Amit R.L. Persad, Medicine & Dentistry Supervisor: Roseline Godbout

Zofia Prus-Czarnecka, Medicine & Dentistry Supervisor: Peter E. Light

Kaylynn Purdy, Medicine & Dentistry Supervisor: Douglas W. Zochodne

Ali H. Qadri, Medicine & Dentistry Supervisor: Joseph R. Casey

Bilal Qarni, Medicine & Dentistry Supervisor: Aminu Bello

Steven Quan, Pharmacy and Pharmaceutical Sciences Supervisor: John M. Seubert

Yasmin Rafiei, Medicine & Dentistry Supervisor: A. M. James Shapiro


Jahanara Rajwani, School of Public Health Supervisor: Stephanie Yanow

Brock Randolph, Medicine & Dentistry Supervisor: Troy A. Baldwin

Parnian Riaz, Medicine & Dentistry Supervisor: Ken S. Butcher

Stewart R. Rowe, Medicine & Dentistry Supervisor: Sandra T. Davidge

Bradley Rutherford, Medicine & Dentistry Supervisor: Howard S. Young

Jaskiran K. Sandha, Medicine & Dentistry Supervisor: Darren H. Freed

Julia L. Sawatzky, Medicine & Dentistry Supervisor: Lisa A. Hartling

Naveet Sohi, Medicine & Dentistry Supervisor: Sanjay Kalra

Morgan Sosniuk, Medicine & Dentistry Supervisor: Lori J. West

Cole Sugden, Medicine & Dentistry Supervisor: Ian R. Winship

Emily Sunwoo, Medicine & Dentistry Supervisor: Michael Weinfeld

Eszter Szepesvari, Medicine & Dentistry Supervisor: Ian R. Winship

Jeffrey Zhi-Hong Tran, Science Supervisor: Todd L. Lowary

Calvin Tseng, Medicine & Dentistry Supervisor: Ian M. MacDonald

Vishnu Vasanthan, Medicine & Dentistry Supervisor: Jayan Nagendran

Harris C. Wang, Medicine & Dentistry Supervisor: Ian Paterson

Yiqun Wang, Science Supervisor: Robert E. Campbell

Michael R. Williamson, Science Supervisor: Frederick Colbourne

John D. Wink, Medicine & Dentistry Supervisor: A. M. James Shapiro

Andrew G. Woodman, Medicine & Dentistry Supervisor: Stephane Bourque

Yilun Wu, Medicine & Dentistry Supervisor: Darren H. Freed

Andrew Xiao, Medicine & Dentistry Supervisor: J. N. Mark Glover

Zhihao Xu, Medicine & Dentistry Supervisor: Ronald B. Moore

Kelly M. Zerr, Medicine & Dentistry Supervisor: Joel B. Dacks

Rahel T. Zewude, Medicine & Dentistry Supervisor: Ken S. Butcher

Xu Anne Zhang, Medicine & Dentistry Supervisor: Jack H. Jhamandas

Kasia Zubkow, Medicine & Dentistry Supervisor: Bradley J. Kerr

UNIVERSITY OF CALGARY

Anish Arora, Cumming School of Medicine Supervisor: Naweed I. Syed

Rahul K. Arora, Cumming School of Medicine Supervisor: Don Morris

Bryce A.A. Besler, Schulich School of Engineering Supervisor: Elise C. Fear

Rhiannon E. Brett, Veterinary Medicine Supervisor: Patrick J. Whelan

Sage A. Brown, Arts Supervisor: Penny M. Pexman

William (Cameron) Buie, Cumming School of Medicine Supervisor: Paul L. Beck

Jessica Cao, Cumming School of Medicine Supervisor: Wallace K. MacNaughton

Stefan Ceklic, Cumming School of Medicine Supervisor: Anthony B. Schryvers

Clement K.O. Chan, Veterinary Medicine Supervisor: James C. Cross

Leona Chan, Cumming School of Medicine Supervisor: Xi-Long Zheng


Dirk A. Chisholm, Cumming School of Medicine Supervisor: Brent E. Hagel

Gerard M. Coughlin, Cumming School of Medicine Supervisor: Deborah M. Kurrasch

Sharon Feng, Cumming School of Medicine Supervisor: Stephen Freedman

Chaitanya Gandhi, Cumming School of Medicine Supervisor: Matthew N. Hill

Brianna M. Ghali, Kinesiology Supervisor: Carolyn A. Emery

Jill Girgulis, Cumming School of Medicine Supervisor: Rajiv Midha

Katherine Girgulis, Cumming School of Medicine Supervisor: Karen M. Barlow

Jordan N. Haidey, Veterinary Medicine Supervisor: Tuan Trang

Alexander Harris, Cumming School of Medicine Supervisor: Paul L. Beck

Zachary Hong, Cumming School of Medicine Supervisor: Shelagh B. Coutts

Rhys P. Johnson, Cumming School of Medicine Supervisor: Christine M. Friedenreich

Anna Kim, Cumming School of Medicine Supervisor: Sarah J. Childs

Si Yong Kim, Kinesiology Supervisor: Walter Herzog

Aaron J. Lanz, Cumming School of Medicine Supervisor: Jaideep S. Bains

Keith C. K. Lau, Cumming School of Medicine Supervisor: Douglas J. Mahoney

Miranda C. Lee, Science Supervisor: Sergei Y. Noskov

Danielle C. Lefebvre, Arts Supervisor: Vina M. Goghari

Katherine Li, Cumming School of Medicine Supervisor: Gerald W. Zamponi

Jenny Q. Liao, Cumming School of Medicine Supervisor: Gregory Cairncross

Chuyang (Aaron) Lin, Science Supervisor: Joe J. Harrison

Fangyi Liu, Science Supervisor: Joe J. Harrison

JianRui (Peter) Liu, Cumming School of Medicine Supervisor: Don Morris

Lindsey Logan, Cumming School of Medicine Supervisor: Sean P. Dukelow

Trevor Low, Cumming School of Medicine Supervisor: Brian L. Brooks

Keon Ma, Cumming School of Medicine Supervisor: Frank P. MacMaster

Ajay Mahajan, Cumming School of Medicine Supervisor: Philip A. Barber

Getanshu Malik, Cumming School of Medicine Supervisor: Henry J. Duff

Lorenzo Marcil, Cumming School of Medicine Supervisor: Karen M. Barlow

Madison Milne-Ives, Cumming School of Medicine Supervisor: Paolo Federico

Daniel A. Moussienko, Cumming School of Medicine Supervisor: Susan P. Lees-Miller

Sujay Nagaraj, Cumming School of Medicine Supervisor: Cheryl Barnabe

Julie A. Osgood, Cumming School of Medicine Supervisor: Jillian S. Parboosingh

Ayodele E. Oyeyemi, Science Supervisor: Andre G. Buret

Kanwar G.S. Pannu, Cumming School of Medicine Supervisor: Eric W. Smith

Daniel S. Park, Cumming School of Medicine Supervisor: Paul W. M. Fedak

John SeiYoung Park, Cumming School of Medicine Supervisor: Todd J. Anderson

Suhyeon Park, Cumming School of Medicine Supervisor: Ki-Young Lee

Joey Poon, Cumming School of Medicine Supervisor: Derek M. McKay


Joey C. Prisnie, Cumming School of Medicine Supervisor: Nathalie Jette

Kristina Quan, Cumming School of Medicine Supervisor: David A. Hart

Jung Kuo Ra, Veterinary Medicine Supervisor: M. Faizal Abdul-Careem

Elliott M. Reichardt, Cumming School of Medicine Supervisor: Bryan G. Yipp

Mu Qing (Austin) Ren, Cumming School of Medicine Supervisor: Richard Leigh

Madison A. Riddell, Cumming School of Medicine Supervisor: C. Adam Kirton

Paul Riek, Kinesiology Supervisor: Walter Herzog

Prajay Shah, Veterinary Medicine Supervisor: Jeffrey A. Biernaskie

Sarthak Sinha, Veterinary Medicine Supervisor: Jeffrey A. Biernaskie

Philip J. Surmanowicz, Cumming School of Medicine Supervisor: Christopher H. Mody

Weiwen (David) Tang, Cumming School of Medicine Supervisor: Voon Wee Yong

Leonie C. A. Tesorero, Cumming School of Medicine Supervisor: William A. Ghali

Siobhan K. Thornton, Cumming School of Medicine Supervisor: Deborah M. Dewey

Michael R. Tom, Cumming School of Medicine Supervisor: Subrata Ghosh

Drayton Trumble, Cumming School of Medicine Supervisor: Eddy S. Lang

Mohit Vohra, Cumming School of Medicine Supervisor: Rajiv Midha

Gabrielle O. Wagner, Cumming School of Medicine Supervisor: Michael D. Hill

Miranda Wan, Cumming School of Medicine Supervisor: Gerald W. Zamponi

Yundi Wang, Cumming School of Medicine Supervisor: Sui R. (Wayne) Chen

Felix Wei, Cumming School of Medicine Supervisor: C. Adam Kirton

Alexis T. Wilson, Cumming School of Medicine Supervisor: Michael D. Hill

Alexander Wong, Cumming School of Medicine Supervisor: Derek V. Exner

Sydney Yee, Cumming School of Medicine Supervisor: Eric W. Smith

Aran Yukseloglu, Cumming School of Medicine Supervisor: Peter K. Stys

Yiming Michael Zhu, Cumming School of Medicine Supervisor: Todd J. Anderson

Jeremy H. Zuo, Cumming School of Medicine Supervisor: Franciscus A. van der Hoorn

UNIVERSITY OF LETHBRIDGE

Alycia N. Amatto, Arts & Science Supervisor: Ute Kothe

Lindsay Amatto, Arts & Science Supervisor: Robbin L. Gibb

Cecilia A. Badenhorst, Arts & Science Supervisor: Aaron Gruber

Ana Canabrava Carvalho, Arts & Science Supervisor: Bryan E. Kolb

Nathan P. B. Grigg, Arts & Science Supervisor: Andrew N. Iwaniuk

Megan S. Malach, Arts & Science Supervisor: Olga Kovalchuk

Janet Poplawski, Arts & Science Supervisor: Gerlinde A. Metz

Amanda M. Weiler, Arts & Science Supervisor: Gerlinde A. Metz

Lauren Williams, Arts & Science Supervisor: Andrew N. Iwaniuk

ALBERTA INNOVATES - HEALTH SOLUTIONSSuite 1500, 10104 - 103 AvenueEdmonton, Alberta T5J 4A7

Phone: (780) 423-5727Toll-free: 1-877-423-5727Fax: (780) 429-3509E-mail: [email protected]

aihealthsolutions.ca

Documents

Annual Report - Alberta Innovates · 2019-08-21 · optimal health and healthcare. Within AIHS, we created the Partnership Office whose members have strong established relationships